"Term","Jaccard","Odds_Ratio","Fold_Enrichment","PValue","FDR","Genes"
"GO:0003182~coronary sinus valve morphogenesis",0.0526315789473684,Inf,1039.21052631579,0.000962268928842769,0.0317823680497783,"4851"
"GO:0007440~foregut morphogenesis",0.0526315789473684,Inf,1039.21052631579,0.000962268928842769,0.0317823680497783,"4851"
"GO:0003270~Notch signaling pathway involved in regulation of secondary heart field cardioblast proliferation",0.0526315789473684,Inf,1039.21052631579,0.000962268928842769,0.0317823680497783,"4851"
"GO:0060768~regulation of epithelial cell proliferation involved in prostate gland development",0.0526315789473684,Inf,1039.21052631579,0.000962268928842769,0.0317823680497783,"4851"
"GO:0060843~venous endothelial cell differentiation",0.0526315789473684,Inf,1039.21052631579,0.000962268928842769,0.0317823680497783,"4851"
"GO:0060001~minus-end directed microfilament motor activity",0.0526315789473684,Inf,1039.21052631579,0.000962268928842769,0.0317823680497783,"4646"
"GO:0003241~growth involved in heart morphogenesis",0.05,1091.14561402326,519.605263157895,0.00192366058657933,0.0358506144328846,"4851"
"GO:0021515~cell differentiation in spinal cord",0.05,1091.14561402326,519.605263157895,0.00192366058657933,0.0358506144328846,"4851"
"GO:0061344~regulation of cell adhesion involved in heart morphogenesis",0.05,1091.14561402326,519.605263157895,0.00192366058657933,0.0358506144328846,"4851"
"GO:0003169~coronary vein morphogenesis",0.05,1091.14561402326,519.605263157895,0.00192366058657933,0.0358506144328846,"4851"
"GO:0070342~brown fat cell proliferation",0.05,1091.14561402326,519.605263157895,0.00192366058657933,0.0358506144328846,"8878"
"GO:0036372~opsin transport",0.05,1091.14561402326,519.605263157895,0.00192366058657933,0.0358506144328846,"9371"
"GO:0003252~negative regulation of cell proliferation involved in heart valve morphogenesis",0.05,1091.14561402326,519.605263157895,0.00192366058657933,0.0358506144328846,"4851"
"GO:0003160~endocardium morphogenesis",0.05,1091.14561402326,519.605263157895,0.00192366058657933,0.0358506144328846,"4851"
"GO:0019417~sulfur oxidation",0.05,1091.14561402326,519.605263157895,0.00192366058657933,0.0358506144328846,"9645"
"GO:0003213~cardiac right atrium morphogenesis",0.05,1091.14561402326,519.605263157895,0.00192366058657933,0.0358506144328846,"4851"
"GO:1903849~positive regulation of aorta morphogenesis",0.05,1091.14561402326,519.605263157895,0.00192366058657933,0.0358506144328846,"4851"
"GO:0004478~methionine adenosyltransferase activity",0.05,1091.14561402326,519.605263157895,0.00192366058657933,0.0358506144328846,"4144"
"GO:0003209~cardiac atrium morphogenesis",0.0909090909090909,754.078167089966,415.684210526316,8.75761249910956e-06,0.00707446454368608,"4851, 6654"
"GO:0072017~distal tubule development",0.0476190476190476,540.386450667648,346.40350877193,0.00288417572859712,0.0358506144328846,"4851"
"GO:0070141~response to UV-A",0.0476190476190476,540.386450667648,346.40350877193,0.00288417572859712,0.0358506144328846,"595"
"GO:2000974~negative regulation of pro-B cell differentiation",0.0476190476190476,540.386450667648,346.40350877193,0.00288417572859712,0.0358506144328846,"4851"
"GO:0000320~re-entry into mitotic cell cycle",0.0476190476190476,540.386450667648,346.40350877193,0.00288417572859712,0.0358506144328846,"595"
"GO:0009912~auditory receptor cell fate commitment",0.0476190476190476,540.386450667648,346.40350877193,0.00288417572859712,0.0358506144328846,"4851"
"GO:1902339~positive regulation of apoptotic process involved in morphogenesis",0.0476190476190476,540.386450667648,346.40350877193,0.00288417572859712,0.0358506144328846,"4851"
"GO:0001959~regulation of cytokine-mediated signaling pathway",0.0476190476190476,540.386450667648,346.40350877193,0.00288417572859712,0.0358506144328846,"3654"
"GO:0060979~vasculogenesis involved in coronary vascular morphogenesis",0.0476190476190476,540.386450667648,346.40350877193,0.00288417572859712,0.0358506144328846,"4851"
"GO:0006543~glutamine catabolic process",0.0476190476190476,540.386450667648,346.40350877193,0.00288417572859712,0.0358506144328846,"2744"
"GO:0099565~chemical synaptic transmission, postsynaptic",0.0476190476190476,540.386450667648,346.40350877193,0.00288417572859712,0.0358506144328846,"4851"
"GO:0060948~cardiac vascular smooth muscle cell development",0.0476190476190476,540.386450667648,346.40350877193,0.00288417572859712,0.0358506144328846,"4851"
"GO:0060528~secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development",0.0476190476190476,540.386450667648,346.40350877193,0.00288417572859712,0.0358506144328846,"4851"
"GO:1902263~apoptotic process involved in embryonic digit morphogenesis",0.0476190476190476,540.386450667648,346.40350877193,0.00288417572859712,0.0358506144328846,"4851"
"GO:2001027~negative regulation of endothelial cell chemotaxis",0.0476190476190476,540.386450667648,346.40350877193,0.00288417572859712,0.0358506144328846,"4851"
"GO:0003207~cardiac chamber formation",0.0476190476190476,540.386450667648,346.40350877193,0.00288417572859712,0.0358506144328846,"4851"
"GO:0003192~mitral valve formation",0.0476190476190476,540.386450667648,346.40350877193,0.00288417572859712,0.0358506144328846,"4851"
"GO:0042670~retinal cone cell differentiation",0.0476190476190476,540.386450667648,346.40350877193,0.00288417572859712,0.0358506144328846,"4851"
"GO:0071211~protein targeting to vacuole involved in autophagy",0.0476190476190476,540.386450667648,346.40350877193,0.00288417572859712,0.0358506144328846,"8878"
"GO:1904693~midbrain morphogenesis",0.0476190476190476,540.386450667648,346.40350877193,0.00288417572859712,0.0358506144328846,"6654"
"GO:0120501~F-actin monooxygenase activity",0.0476190476190476,540.386450667648,346.40350877193,0.00288417572859712,0.0358506144328846,"9645"
"GO:0003344~pericardium morphogenesis",0.0833333333333333,457.336791460667,296.917293233083,1.8369880369576e-05,0.00707446454368608,"4851, 6654"
"GO:0001667~ameboidal-type cell migration",0.0454545454545455,359.879010353491,259.802631578947,0.00384381510967058,0.0361256119250341,"10163"
"GO:0007296~vitellogenesis",0.0454545454545455,359.879010353491,259.802631578947,0.00384381510967058,0.0361256119250341,"6654"
"GO:0060842~arterial endothelial cell differentiation",0.0454545454545455,359.879010353491,259.802631578947,0.00384381510967058,0.0361256119250341,"4851"
"GO:0072148~epithelial cell fate commitment",0.0454545454545455,359.879010353491,259.802631578947,0.00384381510967058,0.0361256119250341,"4851"
"GO:0002085~inhibition of neuroepithelial cell differentiation",0.0454545454545455,359.879010353491,259.802631578947,0.00384381510967058,0.0361256119250341,"4851"
"GO:0006556~S-adenosylmethionine biosynthetic process",0.0454545454545455,359.879010353491,259.802631578947,0.00384381510967058,0.0361256119250341,"4144"
"GO:0072144~glomerular mesangial cell development",0.0454545454545455,359.879010353491,259.802631578947,0.00384381510967058,0.0361256119250341,"4851"
"GO:0062043~positive regulation of cardiac epithelial to mesenchymal transition",0.0454545454545455,359.879010353491,259.802631578947,0.00384381510967058,0.0361256119250341,"4851"
"GO:0061384~heart trabecula morphogenesis",0.08,378.992798299742,259.802631578947,2.44791160681179e-05,0.00707446454368608,"4851, 6654"
"GO:0003219~cardiac right ventricle formation",0.0454545454545455,359.879010353491,259.802631578947,0.00384381510967058,0.0361256119250341,"4851"
"GO:0003157~endocardium development",0.0454545454545455,359.879010353491,259.802631578947,0.00384381510967058,0.0361256119250341,"4851"
"GO:2000973~regulation of pro-B cell differentiation",0.0454545454545455,359.879010353491,259.802631578947,0.00384381510967058,0.0361256119250341,"6654"
"GO:0003273~cell migration involved in endocardial cushion formation",0.0454545454545455,359.879010353491,259.802631578947,0.00384381510967058,0.0361256119250341,"4851"
"GO:0006537~glutamate biosynthetic process",0.0454545454545455,359.879010353491,259.802631578947,0.00384381510967058,0.0361256119250341,"2744"
"GO:0007386~compartment pattern specification",0.0454545454545455,359.879010353491,259.802631578947,0.00384381510967058,0.0361256119250341,"4851"
"GO:0045608~negative regulation of inner ear auditory receptor cell differentiation",0.0454545454545455,359.879010353491,259.802631578947,0.00384381510967058,0.0361256119250341,"4851"
"GO:1901201~regulation of extracellular matrix assembly",0.0454545454545455,359.879010353491,259.802631578947,0.00384381510967058,0.0361256119250341,"4851"
"GO:0072044~collecting duct development",0.0454545454545455,359.879010353491,259.802631578947,0.00384381510967058,0.0361256119250341,"4851"
"GO:0003332~negative regulation of extracellular matrix constituent secretion",0.0454545454545455,359.879010353491,259.802631578947,0.00384381510967058,0.0361256119250341,"4851"
"GO:0004359~glutaminase activity",0.0454545454545455,359.879010353491,259.802631578947,0.00384381510967058,0.0361256119250341,"2744"
"30.Kinesin_superfamily_proteins",0.0434782608695652,272.867928429476,207.842105263158,0.00480257948396356,0.0382881509204268,"9371"
"GO:0072538~T-helper 17 type immune response",0.0434782608695652,272.867928429476,207.842105263158,0.00480257948396356,0.0382881509204268,"4851"
"GO:0051046~regulation of secretion",0.0434782608695652,272.867928429476,207.842105263158,0.00480257948396356,0.0382881509204268,"4646"
"GO:0009957~epidermal cell fate specification",0.0434782608695652,272.867928429476,207.842105263158,0.00480257948396356,0.0382881509204268,"4851"
"GO:0060354~negative regulation of cell adhesion molecule production",0.0434782608695652,272.867928429476,207.842105263158,0.00480257948396356,0.0382881509204268,"4851"
"GO:0060956~endocardial cell differentiation",0.0434782608695652,272.867928429476,207.842105263158,0.00480257948396356,0.0382881509204268,"4851"
"GO:0001554~luteolysis",0.0434782608695652,272.867928429476,207.842105263158,0.00480257948396356,0.0382881509204268,"4851"
"GO:0061431~cellular response to methionine",0.0434782608695652,272.867928429476,207.842105263158,0.00480257948396356,0.0382881509204268,"4144"
"GO:0120170~intraciliary transport particle B binding",0.0434782608695652,272.867928429476,207.842105263158,0.00480257948396356,0.0382881509204268,"9371"
"R-HSA-9754119~Drug-mediated inhibition of CDK4/CDK6 activity",0.0434782608695652,272.867928429476,207.842105263158,0.00480257948396356,0.0382881509204268,"595"
"R-HSA-2644607~Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling",0.0434782608695652,272.867928429476,207.842105263158,0.00480257948396356,0.0382881509204268,"4851"
"R-HSA-2644605~FBXW7 Mutants and NOTCH1 in Cancer",0.0434782608695652,272.867928429476,207.842105263158,0.00480257948396356,0.0382881509204268,"4851"
"WP3656:Interleukin 1 induced activation of NF kB",0.0740740740740741,285.527640556716,207.842105263158,3.92962920775735e-05,0.00757108560694584,"3654, 8878"
"2.Cytokine_Receptors",0.0416666666666667,216.00027301788,173.201754385965,0.00576046960502752,0.0391711933141871,"6654"
"68.Mitogen_signaling_in_growth_control",0.0416666666666667,216.00027301788,173.201754385965,0.00576046960502752,0.0391711933141871,"6654"
"101.Gprot_coupled_Rec_MAP_Kinase",0.0416666666666667,216.00027301788,173.201754385965,0.00576046960502752,0.0391711933141871,"6654"
"GO:0014807~regulation of somitogenesis",0.0416666666666667,216.00027301788,173.201754385965,0.00576046960502752,0.0391711933141871,"4851"
"GO:0090461~intracellular glutamate homeostasis",0.0416666666666667,216.00027301788,173.201754385965,0.00576046960502752,0.0391711933141871,"2744"
"GO:0014031~mesenchymal cell development",0.0416666666666667,216.00027301788,173.201754385965,0.00576046960502752,0.0391711933141871,"4851"
"GO:0030262~apoptotic nuclear changes",0.0416666666666667,216.00027301788,173.201754385965,0.00576046960502752,0.0391711933141871,"10904"
"GO:0098780~response to mitochondrial depolarisation",0.0416666666666667,216.00027301788,173.201754385965,0.00576046960502752,0.0391711933141871,"8878"
"GO:0072383~plus-end-directed vesicle transport along microtubule",0.0416666666666667,216.00027301788,173.201754385965,0.00576046960502752,0.0391711933141871,"9371"
"GO:0034134~toll-like receptor 2 signaling pathway",0.0416666666666667,216.00027301788,173.201754385965,0.00576046960502752,0.0391711933141871,"3654"
"GO:0007100~mitotic centrosome separation",0.0416666666666667,216.00027301788,173.201754385965,0.00576046960502752,0.0391711933141871,"9371"
"GO:0033081~regulation of T cell differentiation in thymus",0.0416666666666667,216.00027301788,173.201754385965,0.00576046960502752,0.0391711933141871,"6654"
"GO:0046533~negative regulation of photoreceptor cell differentiation",0.0416666666666667,216.00027301788,173.201754385965,0.00576046960502752,0.0391711933141871,"4851"
"R-HSA-8849470~PTK6 Regulates Cell Cycle",0.0416666666666667,216.00027301788,173.201754385965,0.00576046960502752,0.0391711933141871,"595"
"WP2253:Pilocytic astrocytoma",0.0416666666666667,216.00027301788,173.201754385965,0.00576046960502752,0.0391711933141871,"6654"
"hsa00470_D-Amino_acid_metabolism",0.0416666666666667,216.00027301788,173.201754385965,0.00576046960502752,0.0391711933141871,"2744"
"R-HSA-209543~p75NTR recruits signalling complexes",0.0666666666666667,207.871704325932,159.878542510121,6.79963756111113e-05,0.00977213277367493,"3654, 8878"
"R-HSA-209560~NF-kB is activated and signals survival",0.0666666666666667,207.871704325932,159.878542510121,6.79963756111113e-05,0.00977213277367493,"3654, 8878"
"GO:0044321~response to leptin",0.04,181.441393124471,148.458646616541,0.00671748622580415,0.0417364463738037,"595"
"GO:0061101~neuroendocrine cell differentiation",0.04,181.441393124471,148.458646616541,0.00671748622580415,0.0417364463738037,"4851"
"GO:0072673~lamellipodium morphogenesis",0.04,181.441393124471,148.458646616541,0.00671748622580415,0.0417364463738037,"10163"
"GO:0071228~cellular response to tumor cell",0.04,181.441393124471,148.458646616541,0.00671748622580415,0.0417364463738037,"4851"
"GO:0008063~Toll signaling pathway",0.04,181.441393124471,148.458646616541,0.00671748622580415,0.0417364463738037,"3654"
"GO:0098971~anterograde dendritic transport of neurotransmitter receptor complex",0.04,181.441393124471,148.458646616541,0.00671748622580415,0.0417364463738037,"9371"
"R-HSA-2660826~Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant",0.04,181.441393124471,148.458646616541,0.00671748622580415,0.0417364463738037,"4851"
"R-HSA-2660825~Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant",0.04,181.441393124471,148.458646616541,0.00671748622580415,0.0417364463738037,"4851"
"R-HSA-9034864~Activated NTRK3 signals through RAS",0.04,181.441393124471,148.458646616541,0.00671748622580415,0.0417364463738037,"6654"
"R-HSA-112412~SOS-mediated signalling",0.04,181.441393124471,148.458646616541,0.00671748622580415,0.0417364463738037,"6654"
"WP5213:Amino acid metabolism in triple negative breast cancer cells",0.04,181.441393124471,148.458646616541,0.00671748622580415,0.0417364463738037,"2744"
"GO:2000601~positive regulation of Arp2/3 complex-mediated actin nucleation",0.0384615384615385,155.029017733556,129.901315789474,0.00767363009862354,0.0417364463738037,"10163"
"GO:0035148~tube formation",0.0384615384615385,155.029017733556,129.901315789474,0.00767363009862354,0.0417364463738037,"4851"
"GO:0038172~interleukin-33-mediated signaling pathway",0.0384615384615385,155.029017733556,129.901315789474,0.00767363009862354,0.0417364463738037,"3654"
"GO:0033601~positive regulation of mammary gland epithelial cell proliferation",0.0384615384615385,155.029017733556,129.901315789474,0.00767363009862354,0.0417364463738037,"595"
"GO:0050793~regulation of developmental process",0.0606060606060606,164.567423093704,129.901315789474,0.000104429833645825,0.00993839565762732,"1490, 4851"
"GO:0060740~prostate gland epithelium morphogenesis",0.0384615384615385,155.029017733556,129.901315789474,0.00767363009862354,0.0417364463738037,"4851"
"GO:0097300~programmed necrotic cell death",0.0384615384615385,155.029017733556,129.901315789474,0.00767363009862354,0.0417364463738037,"79065"
"GO:0060253~negative regulation of glial cell proliferation",0.0384615384615385,155.029017733556,129.901315789474,0.00767363009862354,0.0417364463738037,"4851"
"GO:0045955~negative regulation of calcium ion-dependent exocytosis",0.0384615384615385,155.029017733556,129.901315789474,0.00767363009862354,0.0417364463738037,"4851"
"GO:0007221~positive regulation of transcription of Notch receptor target",0.0384615384615385,155.029017733556,129.901315789474,0.00767363009862354,0.0417364463738037,"4851"
"R-HSA-9818749~Regulation of NFE2L2 gene expression",0.0384615384615385,155.029017733556,129.901315789474,0.00767363009862354,0.0417364463738037,"4851"
"R-HSA-2428933~SHC-related events triggered by IGF1R",0.0384615384615385,155.029017733556,129.901315789474,0.00767363009862354,0.0417364463738037,"6654"
"R-HSA-193639~p75NTR signals via NF-kB",0.0606060606060606,164.567423093704,129.901315789474,0.000104429833645825,0.00993839565762732,"3654, 8878"
"R-HSA-9026519~Activated NTRK2 signals through RAS",0.0384615384615385,155.029017733556,129.901315789474,0.00767363009862354,0.0417364463738037,"6654"
"R-HSA-5083630~Defective LFNG causes SCDO3",0.0384615384615385,155.029017733556,129.901315789474,0.00767363009862354,0.0417364463738037,"4851"
"R-HSA-8951430~RUNX3 regulates WNT signaling",0.0384615384615385,155.029017733556,129.901315789474,0.00767363009862354,0.0417364463738037,"595"
"R-HSA-8951671~RUNX3 regulates YAP1-mediated transcription",0.0384615384615385,155.029017733556,129.901315789474,0.00767363009862354,0.0417364463738037,"1490"
"WP3926:ApoE and miR 146 in inflammation and atherosclerosis",0.0384615384615385,155.029017733556,129.901315789474,0.00767363009862354,0.0417364463738037,"3654"
"92.Ancient_Host_Defense_Pathways",0.037037037037037,135.875781619532,115.46783625731,0.00862890197520683,0.0417364463738037,"3654"
"17.Activators-CAM",0.037037037037037,135.875781619532,115.46783625731,0.00862890197520683,0.0417364463738037,"3654"
"GO:0110076~negative regulation of ferroptosis",0.037037037037037,135.875781619532,115.46783625731,0.00862890197520683,0.0417364463738037,"8878"
"GO:0003162~atrioventricular node development",0.037037037037037,135.875781619532,115.46783625731,0.00862890197520683,0.0417364463738037,"4851"
"GO:0034162~toll-like receptor 9 signaling pathway",0.037037037037037,135.875781619532,115.46783625731,0.00862890197520683,0.0417364463738037,"3654"
"GO:0003208~cardiac ventricle morphogenesis",0.037037037037037,135.875781619532,115.46783625731,0.00862890197520683,0.0417364463738037,"4851"
"GO:0034214~protein hexamerization",0.037037037037037,135.875781619532,115.46783625731,0.00862890197520683,0.0417364463738037,"4144"
"GO:0060982~coronary artery morphogenesis",0.037037037037037,135.875781619532,115.46783625731,0.00862890197520683,0.0417364463738037,"4851"
"GO:0046578~regulation of Ras protein signal transduction",0.037037037037037,135.875781619532,115.46783625731,0.00862890197520683,0.0417364463738037,"8878"
"GO:0051057~positive regulation of small GTPase mediated signal transduction",0.037037037037037,135.875781619532,115.46783625731,0.00862890197520683,0.0417364463738037,"6654"
"GO:0048103~somatic stem cell division",0.037037037037037,135.875781619532,115.46783625731,0.00862890197520683,0.0417364463738037,"4851"
"GO:0097400~interleukin-17-mediated signaling pathway",0.037037037037037,135.875781619532,115.46783625731,0.00862890197520683,0.0417364463738037,"4851"
"GO:1905719~protein localization to perinuclear region of cytoplasm",0.037037037037037,135.875781619532,115.46783625731,0.00862890197520683,0.0417364463738037,"8878"
"GO:0070168~negative regulation of biomineral tissue development",0.037037037037037,135.875781619532,115.46783625731,0.00862890197520683,0.0417364463738037,"4851"
"GO:0016174~NAD(P)H oxidase H2O2-forming activity",0.037037037037037,135.875781619532,115.46783625731,0.00862890197520683,0.0417364463738037,"9645"
"R-HSA-8951936~RUNX3 regulates p14-ARF",0.037037037037037,135.875781619532,115.46783625731,0.00862890197520683,0.0417364463738037,"595"
"R-HSA-2179392~EGFR Transactivation by Gastrin",0.037037037037037,135.875781619532,115.46783625731,0.00862890197520683,0.0417364463738037,"6654"
"R-HSA-1912399~Pre-NOTCH Processing in the Endoplasmic Reticulum",0.037037037037037,135.875781619532,115.46783625731,0.00862890197520683,0.0417364463738037,"4851"
"WP4785:Somitogenesis in the context of spondylocostal dysostosis",0.037037037037037,135.875781619532,115.46783625731,0.00862890197520683,0.0417364463738037,"4851"
"WP704:Methylation pathways",0.037037037037037,135.875781619532,115.46783625731,0.00862890197520683,0.0417364463738037,"4144"
"54.T-cell_anergy",0.0357142857142857,121.085498005821,103.921052631579,0.00958330260666629,0.0436082438037631,"6654"
"108.Regulating_glucose_transport",0.0357142857142857,121.085498005821,103.921052631579,0.00958330260666629,0.0436082438037631,"6654"
"GO:0032966~negative regulation of collagen biosynthetic process",0.0357142857142857,121.085498005821,103.921052631579,0.00958330260666629,0.0436082438037631,"4851"
"GO:0030048~actin filament-based movement",0.0540540540540541,128.394927682222,103.921052631579,0.000164968097072356,0.0136216514439745,"10163, 4646"
"GO:0035973~aggrephagy",0.0357142857142857,121.085498005821,103.921052631579,0.00958330260666629,0.0436082438037631,"8878"
"GO:0071372~cellular response to follicle-stimulating hormone stimulus",0.0357142857142857,121.085498005821,103.921052631579,0.00958330260666629,0.0436082438037631,"4851"
"GO:0140036~ubiquitin-modified protein reader activity",0.0357142857142857,121.085498005821,103.921052631579,0.00958330260666629,0.0436082438037631,"8878"
"R-HSA-74749~Signal attenuation",0.0357142857142857,121.085498005821,103.921052631579,0.00958330260666629,0.0436082438037631,"6654"
"81.Structure_of_Caps_and_SMACs",0.0344827586206897,109.054520971963,94.4736842105263,0.0105368327435023,0.0436082438037631,"6654"
"GO:0003214~cardiac left ventricle morphogenesis",0.0344827586206897,109.054520971963,94.4736842105263,0.0105368327435023,0.0436082438037631,"4851"
"GO:0048711~positive regulation of astrocyte differentiation",0.0344827586206897,109.054520971963,94.4736842105263,0.0105368327435023,0.0436082438037631,"4851"
"GO:0060379~cardiac muscle cell myoblast differentiation",0.0344827586206897,109.054520971963,94.4736842105263,0.0105368327435023,0.0436082438037631,"4851"
"GO:0072091~regulation of stem cell proliferation",0.0344827586206897,109.054520971963,94.4736842105263,0.0105368327435023,0.0436082438037631,"4851"
"GO:0032330~regulation of chondrocyte differentiation",0.0344827586206897,109.054520971963,94.4736842105263,0.0105368327435023,0.0436082438037631,"1490"
"GO:0033598~mammary gland epithelial cell proliferation",0.0344827586206897,109.054520971963,94.4736842105263,0.0105368327435023,0.0436082438037631,"595"
"GO:1904996~positive regulation of leukocyte adhesion to vascular endothelial cell",0.0344827586206897,109.054520971963,94.4736842105263,0.0105368327435023,0.0436082438037631,"3654"
"GO:0045603~positive regulation of endothelial cell differentiation",0.0344827586206897,109.054520971963,94.4736842105263,0.0105368327435023,0.0436082438037631,"4851"
"GO:2000048~negative regulation of cell-cell adhesion mediated by cadherin",0.0344827586206897,109.054520971963,94.4736842105263,0.0105368327435023,0.0436082438037631,"4851"
"R-HSA-9028731~Activated NTRK2 signals through FRS2 and FRS3",0.0344827586206897,109.054520971963,94.4736842105263,0.0105368327435023,0.0436082438037631,"6654"
"R-HSA-9818030~NFE2L2 regulating tumorigenic genes",0.0344827586206897,109.054520971963,94.4736842105263,0.0105368327435023,0.0436082438037631,"4851"
"R-HSA-5655291~Signaling by FGFR4 in disease",0.0344827586206897,109.054520971963,94.4736842105263,0.0105368327435023,0.0436082438037631,"6654"
"R-HSA-9842663~Signaling by LTK",0.0344827586206897,109.054520971963,94.4736842105263,0.0105368327435023,0.0436082438037631,"6654"
"R-HSA-9634285~Constitutive Signaling by Overexpressed ERBB2",0.0344827586206897,109.054520971963,94.4736842105263,0.0105368327435023,0.0436082438037631,"6654"
"R-HSA-9664873~Pexophagy",0.0344827586206897,109.054520971963,94.4736842105263,0.0105368327435023,0.0436082438037631,"8878"
"R-HSA-8851805~MET activates RAS signaling",0.0344827586206897,109.054520971963,94.4736842105263,0.0105368327435023,0.0436082438037631,"6654"
"WP4157:GABA metabolism aka GHB ",0.0344827586206897,109.054520971963,94.4736842105263,0.0105368327435023,0.0436082438037631,"2744"
"WP4147:PTF1A related regulatory pathway",0.0344827586206897,109.054520971963,94.4736842105263,0.0105368327435023,0.0436082438037631,"4851"
"WP2854:Gene regulatory network modeling somitogenesis ",0.0344827586206897,109.054520971963,94.4736842105263,0.0105368327435023,0.0436082438037631,"4851"
"63.LAT_couples_T-cell_receptor",0.0333333333333333,99.0428939362423,86.6008771929825,0.011489493135611,0.0444209166045696,"6654"
"GO:0051152~positive regulation of smooth muscle cell differentiation",0.0333333333333333,99.0428939362423,86.6008771929825,0.011489493135611,0.0444209166045696,"4851"
"GO:0030042~actin filament depolymerization",0.0333333333333333,99.0428939362423,86.6008771929825,0.011489493135611,0.0444209166045696,"9645"
"GO:0001967~suckling behavior",0.0333333333333333,99.0428939362423,86.6008771929825,0.011489493135611,0.0444209166045696,"2744"
"GO:0003181~atrioventricular valve morphogenesis",0.0333333333333333,99.0428939362423,86.6008771929825,0.011489493135611,0.0444209166045696,"4851"
"GO:0055008~cardiac muscle tissue morphogenesis",0.0333333333333333,99.0428939362423,86.6008771929825,0.011489493135611,0.0444209166045696,"4851"
"GO:0003198~epithelial to mesenchymal transition involved in endocardial cushion formation",0.0333333333333333,99.0428939362423,86.6008771929825,0.011489493135611,0.0444209166045696,"4851"
"GO:0140537~transcription regulator activator activity",0.0333333333333333,99.0428939362423,86.6008771929825,0.011489493135611,0.0444209166045696,"4851"
"GO:0061575~cyclin-dependent protein serine/threonine kinase activator activity",0.0333333333333333,99.0428939362423,86.6008771929825,0.011489493135611,0.0444209166045696,"595"
"GO:0016709~oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen",0.0333333333333333,99.0428939362423,86.6008771929825,0.011489493135611,0.0444209166045696,"9645"
"R-HSA-9673767~Signaling by PDGFRA transmembrane, juxtamembrane and kinase domain mutants",0.0333333333333333,99.0428939362423,86.6008771929825,0.011489493135611,0.0444209166045696,"6654"
"R-HSA-190873~Gap junction degradation",0.0333333333333333,99.0428939362423,86.6008771929825,0.011489493135611,0.0444209166045696,"4646"
"R-HSA-9673770~Signaling by PDGFRA extracellular domain mutants",0.0333333333333333,99.0428939362423,86.6008771929825,0.011489493135611,0.0444209166045696,"6654"
"WP5382:TGFB Smad signaling",0.0333333333333333,99.0428939362423,86.6008771929825,0.011489493135611,0.0444209166045696,"1490"
"GO:0061029~eyelid development in camera-type eye",0.032258064516129,90.8409866919142,79.9392712550607,0.0124412845322776,0.0466952107769898,"6654"
"GO:0045737~positive regulation of cyclin-dependent protein serine/threonine kinase activity",0.032258064516129,90.8409866919142,79.9392712550607,0.0124412845322776,0.0466952107769898,"595"
"GO:0043086~negative regulation of catalytic activity",0.032258064516129,90.8409866919142,79.9392712550607,0.0124412845322776,0.0466952107769898,"4851"
"GO:0032495~response to muramyl dipeptide",0.032258064516129,90.8409866919142,79.9392712550607,0.0124412845322776,0.0466952107769898,"4851"
"GO:0005520~insulin-like growth factor binding",0.032258064516129,90.8409866919142,79.9392712550607,0.0124412845322776,0.0466952107769898,"1490"
"R-HSA-179812~GRB2 events in EGFR signaling",0.032258064516129,90.8409866919142,79.9392712550607,0.0124412845322776,0.0466952107769898,"6654"
"R-HSA-975110~TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling",0.032258064516129,90.8409866919142,79.9392712550607,0.0124412845322776,0.0466952107769898,"3654"
"WP2814:Mammary gland development puberty stage 2 of 4",0.032258064516129,90.8409866919142,79.9392712550607,0.0124412845322776,0.0466952107769898,"595"
"GO:0034144~negative regulation of toll-like receptor 4 signaling pathway",0.03125,84.1193105309501,74.2293233082707,0.0133922076821814,0.0473437066685068,"8878"
"GO:0002087~regulation of respiratory gaseous exchange by nervous system process",0.03125,84.1193105309501,74.2293233082707,0.0133922076821814,0.0473437066685068,"2744"
"GO:0003222~ventricular trabecula myocardium morphogenesis",0.03125,84.1193105309501,74.2293233082707,0.0133922076821814,0.0473437066685068,"4851"
"GO:0048715~negative regulation of oligodendrocyte differentiation",0.03125,84.1193105309501,74.2293233082707,0.0133922076821814,0.0473437066685068,"4851"
"GO:0060317~cardiac epithelial to mesenchymal transition",0.03125,84.1193105309501,74.2293233082707,0.0133922076821814,0.0473437066685068,"4851"
"GO:0060411~cardiac septum morphogenesis",0.03125,84.1193105309501,74.2293233082707,0.0133922076821814,0.0473437066685068,"4851"
"GO:0051291~protein heterooligomerization",0.03125,84.1193105309501,74.2293233082707,0.0133922076821814,0.0473437066685068,"4144"
"GO:0071933~Arp2/3 complex binding",0.03125,84.1193105309501,74.2293233082707,0.0133922076821814,0.0473437066685068,"10163"
"R-HSA-975144~IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation",0.03125,84.1193105309501,74.2293233082707,0.0133922076821814,0.0473437066685068,"3654"
"R-HSA-156581~Methylation",0.03125,84.1193105309501,74.2293233082707,0.0133922076821814,0.0473437066685068,"4144"
"R-HSA-180336~SHC1 events in EGFR signaling",0.03125,84.1193105309501,74.2293233082707,0.0133922076821814,0.0473437066685068,"6654"
"R-HSA-9027284~Erythropoietin activates RAS",0.03125,84.1193105309501,74.2293233082707,0.0133922076821814,0.0473437066685068,"6654"
"R-HSA-937039~IRAK1 recruits IKK complex",0.03125,84.1193105309501,74.2293233082707,0.0133922076821814,0.0473437066685068,"3654"
"R-HSA-1250347~SHC1 events in ERBB4 signaling",0.03125,84.1193105309501,74.2293233082707,0.0133922076821814,0.0473437066685068,"6654"
"R-HSA-428540~Activation of RAC1",0.03125,84.1193105309501,74.2293233082707,0.0133922076821814,0.0473437066685068,"6654"
"R-HSA-8964539~Glutamate and glutamine metabolism",0.03125,84.1193105309501,74.2293233082707,0.0133922076821814,0.0473437066685068,"2744"
"R-HSA-8941856~RUNX3 regulates NOTCH signaling",0.03125,84.1193105309501,74.2293233082707,0.0133922076821814,0.0473437066685068,"4851"
"R-HSA-8983432~Interleukin-15 signaling",0.03125,84.1193105309501,74.2293233082707,0.0133922076821814,0.0473437066685068,"6654"
"WP3969:H19 Rb E2F1 and CDK beta catenin in colorectal cancer",0.03125,84.1193105309501,74.2293233082707,0.0133922076821814,0.0473437066685068,"595"
"104.Insulin_signaling",0.0303030303030303,77.9729375651602,69.280701754386,0.0143422633333916,0.0473704468954306,"6654"
"GO:0030857~negative regulation of epithelial cell differentiation",0.0303030303030303,77.9729375651602,69.280701754386,0.0143422633333916,0.0473704468954306,"595"
"GO:0014044~Schwann cell development",0.0303030303030303,77.9729375651602,69.280701754386,0.0143422633333916,0.0473704468954306,"6654"
"GO:0042491~inner ear auditory receptor cell differentiation",0.0303030303030303,77.9729375651602,69.280701754386,0.0143422633333916,0.0473704468954306,"4646"
"GO:0140694~membraneless organelle assembly",0.0303030303030303,77.9729375651602,69.280701754386,0.0143422633333916,0.0473704468954306,"8878"
"GO:0010614~negative regulation of cardiac muscle hypertrophy",0.0303030303030303,77.9729375651602,69.280701754386,0.0143422633333916,0.0473704468954306,"4851"
"GO:0048011~neurotrophin TRK receptor signaling pathway",0.0303030303030303,77.9729375651602,69.280701754386,0.0143422633333916,0.0473704468954306,"6654"
"GO:0010832~negative regulation of myotube differentiation",0.0303030303030303,77.9729375651602,69.280701754386,0.0143422633333916,0.0473704468954306,"4851"
"R-HSA-2691232~Constitutive Signaling by NOTCH1 HD Domain Mutants",0.0303030303030303,77.9729375651602,69.280701754386,0.0143422633333916,0.0473704468954306,"4851"
"R-HSA-5637810~Constitutive Signaling by EGFRvIII",0.0303030303030303,77.9729375651602,69.280701754386,0.0143422633333916,0.0473704468954306,"6654"
"R-HSA-5637812~Signaling by EGFRvIII in Cancer",0.0303030303030303,77.9729375651602,69.280701754386,0.0143422633333916,0.0473704468954306,"6654"
"R-HSA-354194~GRB2:SOS provides linkage to MAPK signaling for Integrins ",0.0303030303030303,77.9729375651602,69.280701754386,0.0143422633333916,0.0473704468954306,"6654"
"R-HSA-2032785~YAP1- and WWTR1 (TAZ)-stimulated gene expression",0.0303030303030303,77.9729375651602,69.280701754386,0.0143422633333916,0.0473704468954306,"1490"
"R-HSA-2730905~Role of LAT2/NTAL/LAB on calcium mobilization",0.0303030303030303,77.9729375651602,69.280701754386,0.0143422633333916,0.0473704468954306,"6654"
"R-HSA-1433559~Regulation of KIT signaling",0.0303030303030303,77.9729375651602,69.280701754386,0.0143422633333916,0.0473704468954306,"6654"
"R-HSA-2691230~Signaling by NOTCH1 HD Domain Mutants in Cancer",0.0303030303030303,77.9729375651602,69.280701754386,0.0143422633333916,0.0473704468954306,"4851"
"KW-0237~DNA synthesis",0.0303030303030303,77.9729375651602,69.280701754386,0.0143422633333916,0.0473704468954306,"1490"
"WP3971:OSX and miRNAs in tooth development",0.0303030303030303,77.9729375651602,69.280701754386,0.0143422633333916,0.0473704468954306,"4851"
"WP2813:Mammary gland development embryonic development stage 1 of 4",0.0303030303030303,77.9729375651602,69.280701754386,0.0143422633333916,0.0473704468954306,"595"
"WP1545:miRNAs involved in DNA damage response",0.0303030303030303,77.9729375651602,69.280701754386,0.0143422633333916,0.0473704468954306,"595"
"WP3981:miRNA regulation of prostate cancer signaling",0.0416666666666667,79.6445147297699,67.0458404074703,0.000401197608082309,0.0235437950857276,"595, 6654"
"GO:0090051~negative regulation of cell migration involved in sprouting angiogenesis",0.0294117647058824,72.8113536886146,64.9506578947368,0.0152914522333746,0.0481744002068905,"4851"
"GO:0002755~MyD88-dependent toll-like receptor signaling pathway",0.0294117647058824,72.8113536886146,64.9506578947368,0.0152914522333746,0.0481744002068905,"3654"
"GO:0061635~regulation of protein complex stability",0.0294117647058824,72.8113536886146,64.9506578947368,0.0152914522333746,0.0481744002068905,"8878"
"GO:0034497~protein localization to phagophore assembly site",0.0294117647058824,72.8113536886146,64.9506578947368,0.0152914522333746,0.0481744002068905,"79065"
"GO:0010812~negative regulation of cell-substrate adhesion",0.0294117647058824,72.8113536886146,64.9506578947368,0.0152914522333746,0.0481744002068905,"4851"
"GO:0000425~pexophagy",0.0294117647058824,72.8113536886146,64.9506578947368,0.0152914522333746,0.0481744002068905,"8878"
"R-HSA-210744~Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells",0.0294117647058824,72.8113536886146,64.9506578947368,0.0152914522333746,0.0481744002068905,"4851"
"R-HSA-1963640~GRB2 events in ERBB2 signaling",0.0294117647058824,72.8113536886146,64.9506578947368,0.0152914522333746,0.0481744002068905,"6654"
"R-HSA-9034015~Signaling by NTRK3 (TRKC)",0.0294117647058824,72.8113536886146,64.9506578947368,0.0152914522333746,0.0481744002068905,"6654"
"R-HSA-9665348~Signaling by ERBB2 ECD mutants",0.0294117647058824,72.8113536886146,64.9506578947368,0.0152914522333746,0.0481744002068905,"6654"
"R-HSA-9703648~Signaling by FLT3 ITD and TKD mutants",0.0294117647058824,72.8113536886146,64.9506578947368,0.0152914522333746,0.0481744002068905,"6654"
"R-HSA-5205685~PINK1-PRKN Mediated Mitophagy",0.0408163265306122,76.9978193466768,64.9506578947368,0.000427698699654221,0.0235437950857276,"79065, 8878"
"R-HSA-205043~NRIF signals cell death from the nucleus",0.0294117647058824,72.8113536886146,64.9506578947368,0.0152914522333746,0.0481744002068905,"8878"
"WP4928:MAPK pathway in congenital thyroid cancer",0.0294117647058824,72.8113536886146,64.9506578947368,0.0152914522333746,0.0481744002068905,"6654"
"67.Ikaros_and_signaling_inhibitors",0.0285714285714286,68.480470909098,61.1300309597523,0.0162397751289884,0.0487615066210666,"6654"
"99.NF-kB_activation",0.0285714285714286,68.480470909098,61.1300309597523,0.0162397751289884,0.0487615066210666,"3654"
"GO:0017121~plasma membrane phospholipid scrambling",0.0285714285714286,68.480470909098,61.1300309597523,0.0162397751289884,0.0487615066210666,"79065"
"GO:0035988~chondrocyte proliferation",0.0285714285714286,68.480470909098,61.1300309597523,0.0162397751289884,0.0487615066210666,"1490"
"GO:0042129~regulation of T cell proliferation",0.0285714285714286,68.480470909098,61.1300309597523,0.0162397751289884,0.0487615066210666,"6654"
"GO:0031571~mitotic G1 DNA damage checkpoint signaling",0.0285714285714286,68.480470909098,61.1300309597523,0.0162397751289884,0.0487615066210666,"595"
"R-HSA-8934593~Regulation of RUNX1 Expression and Activity",0.0285714285714286,68.480470909098,61.1300309597523,0.0162397751289884,0.0487615066210666,"595"
"R-HSA-9659787~Aberrant regulation of mitotic G1/S transition in cancer due to RB1 defects",0.0285714285714286,68.480470909098,61.1300309597523,0.0162397751289884,0.0487615066210666,"595"
"R-HSA-9661069~Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)",0.0285714285714286,68.480470909098,61.1300309597523,0.0162397751289884,0.0487615066210666,"595"
"R-HSA-5654704~SHC-mediated cascade:FGFR3",0.0285714285714286,68.480470909098,61.1300309597523,0.0162397751289884,0.0487615066210666,"6654"
"WP3413:NOTCH1 regulation of endothelial cell calcification",0.0285714285714286,68.480470909098,61.1300309597523,0.0162397751289884,0.0487615066210666,"4851"
"WP3678:Amplification and expansion of oncogenic pathways as metastatic traits",0.0285714285714286,68.480470909098,61.1300309597523,0.0162397751289884,0.0487615066210666,"4851"
"GO:0017156~calcium-ion regulated exocytosis",0.0277777777777778,64.0992781581741,57.733918128655,0.0171872327664857,0.0502392381251346,"4851"
"GO:2000737~negative regulation of stem cell differentiation",0.0277777777777778,64.0992781581741,57.733918128655,0.0171872327664857,0.0502392381251346,"4851"
"GO:0060749~mammary gland alveolus development",0.0277777777777778,64.0992781581741,57.733918128655,0.0171872327664857,0.0502392381251346,"595"
"GO:0098974~postsynaptic actin cytoskeleton organization",0.0277777777777778,64.0992781581741,57.733918128655,0.0171872327664857,0.0502392381251346,"10163"
"GO:0034727~piecemeal microautophagy of the nucleus",0.0277777777777778,64.0992781581741,57.733918128655,0.0171872327664857,0.0502392381251346,"79065"
"GO:0070986~left/right axis specification",0.0277777777777778,64.0992781581741,57.733918128655,0.0171872327664857,0.0502392381251346,"4851"
"R-HSA-881907~Gastrin-CREB signalling pathway via PKC and MAPK",0.0277777777777778,64.0992781581741,57.733918128655,0.0171872327664857,0.0502392381251346,"6654"
"R-HSA-210993~Tie2 Signaling",0.0277777777777778,64.0992781581741,57.733918128655,0.0171872327664857,0.0502392381251346,"6654"
"WP3877:MYD88 distinct input output pathway",0.0277777777777778,64.0992781581741,57.733918128655,0.0171872327664857,0.0502392381251346,"3654"
"R-HSA-5205647~Mitophagy",0.037037037037037,66.0328101182037,56.1735419630156,0.000572644332540175,0.0300898567462019,"79065, 8878"
"GO:0048708~astrocyte differentiation",0.027027027027027,60.6634643157159,54.6952908587258,0.018133825891514,0.0506345476584305,"4851"
"GO:0048514~blood vessel morphogenesis",0.027027027027027,60.6634643157159,54.6952908587258,0.018133825891514,0.0506345476584305,"6654"
"GO:0003203~endocardial cushion morphogenesis",0.027027027027027,60.6634643157159,54.6952908587258,0.018133825891514,0.0506345476584305,"4851"
"GO:2000811~negative regulation of anoikis",0.027027027027027,60.6634643157159,54.6952908587258,0.018133825891514,0.0506345476584305,"4851"
"GO:0140313~molecular sequestering activity",0.027027027027027,60.6634643157159,54.6952908587258,0.018133825891514,0.0506345476584305,"8878"
"GO:0070064~proline-rich region binding",0.027027027027027,60.6634643157159,54.6952908587258,0.018133825891514,0.0506345476584305,"595"
"GO:0008574~plus-end-directed microtubule motor activity",0.027027027027027,60.6634643157159,54.6952908587258,0.018133825891514,0.0506345476584305,"9371"
"R-HSA-9670439~Signaling by phosphorylated juxtamembrane, extracellular and kinase domain KIT mutants",0.027027027027027,60.6634643157159,54.6952908587258,0.018133825891514,0.0506345476584305,"6654"
"R-HSA-9669938~Signaling by KIT in disease",0.027027027027027,60.6634643157159,54.6952908587258,0.018133825891514,0.0506345476584305,"6654"
"R-HSA-9825892~Regulation of MITF-M-dependent genes involved in cell cycle and proliferation",0.027027027027027,60.6634643157159,54.6952908587258,0.018133825891514,0.0506345476584305,"595"
"R-HSA-1236382~Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants",0.027027027027027,60.6634643157159,54.6952908587258,0.018133825891514,0.0506345476584305,"6654"
"R-HSA-5637815~Signaling by Ligand-Responsive EGFR Variants in Cancer",0.027027027027027,60.6634643157159,54.6952908587258,0.018133825891514,0.0506345476584305,"6654"
"R-HSA-5654688~SHC-mediated cascade:FGFR1",0.027027027027027,60.6634643157159,54.6952908587258,0.018133825891514,0.0506345476584305,"6654"
"R-HSA-5654719~SHC-mediated cascade:FGFR4",0.027027027027027,60.6634643157159,54.6952908587258,0.018133825891514,0.0506345476584305,"6654"
"R-HSA-9703465~Signaling by FLT3 fusion proteins",0.027027027027027,60.6634643157159,54.6952908587258,0.018133825891514,0.0506345476584305,"6654"
"R-HSA-167044~Signalling to RAS",0.027027027027027,60.6634643157159,54.6952908587258,0.018133825891514,0.0506345476584305,"6654"
"KW-0554~One-carbon metabolism",0.027027027027027,60.6634643157159,54.6952908587258,0.018133825891514,0.0506345476584305,"4144"
"WP4478:LTF danger signal response pathway",0.027027027027027,60.6634643157159,54.6952908587258,0.018133825891514,0.0506345476584305,"3654"
"GO:0010821~regulation of mitochondrion organization",0.0263157894736842,57.4818650603552,51.9605263157895,0.0190795552491166,0.0521417632812738,"8878"
"GO:0006541~glutamine metabolic process",0.0263157894736842,57.4818650603552,51.9605263157895,0.0190795552491166,0.0521417632812738,"2744"
"GO:0001502~cartilage condensation",0.0263157894736842,57.4818650603552,51.9605263157895,0.0190795552491166,0.0521417632812738,"1490"
"GO:0045618~positive regulation of keratinocyte differentiation",0.0263157894736842,57.4818650603552,51.9605263157895,0.0190795552491166,0.0521417632812738,"4851"
"GO:0042246~tissue regeneration",0.0263157894736842,57.4818650603552,51.9605263157895,0.0190795552491166,0.0521417632812738,"4851"
"R-HSA-9671555~Signaling by PDGFR in disease",0.0263157894736842,57.4818650603552,51.9605263157895,0.0190795552491166,0.0521417632812738,"6654"
"R-HSA-5654706~FRS-mediated FGFR3 signaling",0.0263157894736842,57.4818650603552,51.9605263157895,0.0190795552491166,0.0521417632812738,"6654"
"WP3927:BMP signaling in eyelid development",0.0263157894736842,57.4818650603552,51.9605263157895,0.0190795552491166,0.0521417632812738,"4851"
"WP5331:Autophagy in pancreatic ductal adenocarcinoma",0.0263157894736842,57.4818650603552,51.9605263157895,0.0190795552491166,0.0521417632812738,"8878"
"GO:0046579~positive regulation of Ras protein signal transduction",0.0256410256410256,54.6210213297532,49.4862155388471,0.020024421583731,0.0537081933893109,"4851"
"GO:0061709~reticulophagy",0.0256410256410256,54.6210213297532,49.4862155388471,0.020024421583731,0.0537081933893109,"79065"
"GO:0003184~pulmonary valve morphogenesis",0.0256410256410256,54.6210213297532,49.4862155388471,0.020024421583731,0.0537081933893109,"4851"
"GO:0001659~temperature homeostasis",0.0256410256410256,54.6210213297532,49.4862155388471,0.020024421583731,0.0537081933893109,"8878"
"R-HSA-1912420~Pre-NOTCH Processing in Golgi",0.0256410256410256,54.6210213297532,49.4862155388471,0.020024421583731,0.0537081933893109,"4851"
"R-HSA-5654699~SHC-mediated cascade:FGFR2",0.0256410256410256,54.6210213297532,49.4862155388471,0.020024421583731,0.0537081933893109,"6654"
"GO:0070498~interleukin-1-mediated signaling pathway",0.025,52.0333728912676,47.2368421052632,0.0209684256391919,0.0547167043767625,"3654"
"GO:0051019~mitogen-activated protein kinase binding",0.025,52.0333728912676,47.2368421052632,0.0209684256391919,0.0547167043767625,"9645"
"GO:0017128~phospholipid scramblase activity",0.025,52.0333728912676,47.2368421052632,0.0209684256391919,0.0547167043767625,"79065"
"R-HSA-1250196~SHC1 events in ERBB2 signaling",0.025,52.0333728912676,47.2368421052632,0.0209684256391919,0.0547167043767625,"6654"
"R-HSA-9665686~Signaling by ERBB2 TMD/JMD mutants",0.025,52.0333728912676,47.2368421052632,0.0209684256391919,0.0547167043767625,"6654"
"R-HSA-5654712~FRS-mediated FGFR4 signaling",0.025,52.0333728912676,47.2368421052632,0.0209684256391919,0.0547167043767625,"6654"
"R-HSA-5654693~FRS-mediated FGFR1 signaling",0.025,52.0333728912676,47.2368421052632,0.0209684256391919,0.0547167043767625,"6654"
"R-HSA-5655332~Signaling by FGFR3 in disease",0.025,52.0333728912676,47.2368421052632,0.0209684256391919,0.0547167043767625,"6654"
"R-HSA-450321~JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1",0.025,52.0333728912676,47.2368421052632,0.0209684256391919,0.0547167043767625,"3654"
"WP3580:Methionine de novo and salvage pathway",0.025,52.0333728912676,47.2368421052632,0.0209684256391919,0.0547167043767625,"4144"
"WP4936:Perturbations to host cell autophagy induced by SARS CoV 2 proteins",0.0327868852459016,55.0285231667358,47.2368421052632,0.000810137085213719,0.0317823680497783,"79065, 8878"
"WP5300:TROP2 regulatory signaling",0.032258064516129,53.7527789730712,46.187134502924,0.0008473318947708,0.0317823680497783,"4851, 595"
"GO:0035855~megakaryocyte development",0.024390243902439,49.5853936101745,45.1830663615561,0.0219115681587303,0.0553051807674503,"10163"
"GO:1900273~positive regulation of long-term synaptic potentiation",0.024390243902439,49.5853936101745,45.1830663615561,0.0219115681587303,0.0553051807674503,"8878"
"GO:0007492~endoderm development",0.024390243902439,49.5853936101745,45.1830663615561,0.0219115681587303,0.0553051807674503,"4851"
"GO:0000422~autophagy of mitochondrion",0.024390243902439,49.5853936101745,45.1830663615561,0.0219115681587303,0.0553051807674503,"8878"
"GO:0048754~branching morphogenesis of an epithelial tube",0.024390243902439,49.5853936101745,45.1830663615561,0.0219115681587303,0.0553051807674503,"4851"
"R-HSA-9013418~RHOBTB2 GTPase cycle",0.024390243902439,49.5853936101745,45.1830663615561,0.0219115681587303,0.0553051807674503,"4646"
"R-HSA-9006115~Signaling by NTRK2 (TRKB)",0.024390243902439,49.5853936101745,45.1830663615561,0.0219115681587303,0.0553051807674503,"6654"
"R-HSA-450302~activated TAK1 mediates p38 MAPK activation",0.024390243902439,49.5853936101745,45.1830663615561,0.0219115681587303,0.0553051807674503,"3654"
"R-HSA-9013422~RHOBTB1 GTPase cycle",0.024390243902439,49.5853936101745,45.1830663615561,0.0219115681587303,0.0553051807674503,"4646"
"WP4224:Purine metabolism and related disorders",0.024390243902439,49.5853936101745,45.1830663615561,0.0219115681587303,0.0553051807674503,"4144"
"WP262:Ebstein Barr virus LMP1 signaling",0.024390243902439,49.5853936101745,45.1830663615561,0.0219115681587303,0.0553051807674503,"3654"
"WP4790:FGF23 signaling in hypophosphatemic rickets and related disorders",0.024390243902439,49.5853936101745,45.1830663615561,0.0219115681587303,0.0553051807674503,"595"
"WP4535:Envelope proteins and their potential roles in EDMD physiopathology",0.0317460317460317,52.4580991936721,45.1830663615561,0.000885339214386675,0.0317823680497783,"1490, 6654"
"hsa00220_Arginine_biosynthesis",0.024390243902439,49.5853936101745,45.1830663615561,0.0219115681587303,0.0553051807674503,"2744"
"hsa04964_Proximal_tubule_bicarbonate_reclamation",0.024390243902439,49.5853936101745,45.1830663615561,0.0219115681587303,0.0553051807674503,"2744"
"GO:0140693~molecular condensate scaffold activity",0.03125,51.2937469146891,44.2217245240761,0.000924157612359799,0.0317823680497783,"6654, 8878"
"GO:0050768~negative regulation of neurogenesis",0.0238095238095238,47.4363884710395,43.3004385964912,0.0228538498849737,0.0563305980107242,"4851"
"GO:0038095~Fc-epsilon receptor signaling pathway",0.0238095238095238,47.4363884710395,43.3004385964912,0.0228538498849737,0.0563305980107242,"6654"
"R-HSA-9013695~NOTCH4 Intracellular Domain Regulates Transcription",0.0238095238095238,47.4363884710395,43.3004385964912,0.0228538498849737,0.0563305980107242,"4851"
"R-HSA-5654700~FRS-mediated FGFR2 signaling",0.0238095238095238,47.4363884710395,43.3004385964912,0.0228538498849737,0.0563305980107242,"6654"
"R-HSA-210500~Glutamate Neurotransmitter Release Cycle",0.0238095238095238,47.4363884710395,43.3004385964912,0.0228538498849737,0.0563305980107242,"2744"
"R-HSA-9013508~NOTCH3 Intracellular Domain Regulates Transcription",0.0238095238095238,47.4363884710395,43.3004385964912,0.0228538498849737,0.0563305980107242,"4851"
"R-HSA-5654708~Downstream signaling of activated FGFR3",0.0238095238095238,47.4363884710395,43.3004385964912,0.0228538498849737,0.0563305980107242,"6654"
"R-HSA-9634638~Estrogen-dependent nuclear events downstream of ESR-membrane signaling",0.0238095238095238,47.4363884710395,43.3004385964912,0.0228538498849737,0.0563305980107242,"595"
"WP2865:IL1 and megakaryocytes in obesity",0.0238095238095238,47.4363884710395,43.3004385964912,0.0228538498849737,0.0563305980107242,"3654"
"WP3646:Hepatitis C and hepatocellular carcinoma",0.0303030303030303,49.1160533176702,42.4167561761547,0.00100422192535127,0.0322466818251687,"595, 6654"
"GO:0060038~cardiac muscle cell proliferation",0.0232558139534884,45.4696998224801,41.5684210526316,0.0237952715599492,0.0571878044143478,"4851"
"GO:0070316~regulation of G0 to G1 transition",0.0232558139534884,45.4696998224801,41.5684210526316,0.0237952715599492,0.0571878044143478,"9275"
"GO:0097150~neuronal stem cell population maintenance",0.0232558139534884,45.4696998224801,41.5684210526316,0.0237952715599492,0.0571878044143478,"4851"
"GO:0060045~positive regulation of cardiac muscle cell proliferation",0.0232558139534884,45.4696998224801,41.5684210526316,0.0237952715599492,0.0571878044143478,"4851"
"GO:0010667~negative regulation of cardiac muscle cell apoptotic process",0.0232558139534884,45.4696998224801,41.5684210526316,0.0237952715599492,0.0571878044143478,"4851"
"GO:0051018~protein kinase A binding",0.0232558139534884,45.4696998224801,41.5684210526316,0.0237952715599492,0.0571878044143478,"10163"
"GO:0070530~K63-linked polyubiquitin modification-dependent protein binding",0.0232558139534884,45.4696998224801,41.5684210526316,0.0237952715599492,0.0571878044143478,"8878"
"R-HSA-9664565~Signaling by ERBB2 KD Mutants",0.0232558139534884,45.4696998224801,41.5684210526316,0.0237952715599492,0.0571878044143478,"6654"
"R-HSA-9006335~Signaling by Erythropoietin",0.0232558139534884,45.4696998224801,41.5684210526316,0.0237952715599492,0.0571878044143478,"6654"
"R-HSA-1643713~Signaling by EGFR in Cancer",0.0232558139534884,45.4696998224801,41.5684210526316,0.0237952715599492,0.0571878044143478,"6654"
"WP3668:Hypothesized pathways in pathogenesis of cardiovascular disease",0.0232558139534884,45.4696998224801,41.5684210526316,0.0237952715599492,0.0571878044143478,"1490"
"GO:0016601~Rac protein signal transduction",0.0227272727272727,43.6982810412551,39.9696356275304,0.0247358339250789,0.0576504516479662,"10163"
"GO:0050900~leukocyte migration",0.0227272727272727,43.6982810412551,39.9696356275304,0.0247358339250789,0.0576504516479662,"6654"
"GO:0001894~tissue homeostasis",0.0227272727272727,43.6982810412551,39.9696356275304,0.0247358339250789,0.0576504516479662,"1490"
"GO:0000423~mitophagy",0.0289855072463768,46.1787579450485,39.9696356275304,0.00113036579087033,0.0343869172170027,"79065, 8878"
"GO:0048589~developmental growth",0.0227272727272727,43.6982810412551,39.9696356275304,0.0247358339250789,0.0576504516479662,"4851"
"GO:0005112~Notch binding",0.0227272727272727,43.6982810412551,39.9696356275304,0.0247358339250789,0.0576504516479662,"4851"
"R-HSA-1227990~Signaling by ERBB2 in Cancer",0.0227272727272727,43.6982810412551,39.9696356275304,0.0247358339250789,0.0576504516479662,"6654"
"R-HSA-5654716~Downstream signaling of activated FGFR4",0.0227272727272727,43.6982810412551,39.9696356275304,0.0247358339250789,0.0576504516479662,"6654"
"WP3658:Wnt beta catenin signaling in leukemia",0.0227272727272727,43.6982810412551,39.9696356275304,0.0247358339250789,0.0576504516479662,"595"
"WP581:EPO receptor signaling",0.0227272727272727,43.6982810412551,39.9696356275304,0.0247358339250789,0.0576504516479662,"6654"
"WP5494:Tyrosine kinase inhibitors in glioblastoma",0.0227272727272727,43.6982810412551,39.9696356275304,0.0247358339250789,0.0576504516479662,"6654"
"WP5495:Targeting YAP in pancreatic ductal adenocarcinoma PDAC ",0.0227272727272727,43.6982810412551,39.9696356275304,0.0247358339250789,0.0576504516479662,"1490"
"WP2878:PPAR alpha pathway",0.0227272727272727,43.6982810412551,39.9696356275304,0.0247358339250789,0.0576504516479662,"595"
"GO:0001782~B cell homeostasis",0.0222222222222222,42.0008300284635,38.4892787524366,0.0256755377211857,0.0587741021894864,"6654"
"GO:0002437~inflammatory response to antigenic stimulus",0.0222222222222222,42.0008300284635,38.4892787524366,0.0256755377211857,0.0587741021894864,"4851"
"GO:2000045~regulation of G1/S transition of mitotic cell cycle",0.028169014084507,44.4187036525649,38.4892787524366,0.0012184766976156,0.035213976561091,"595, 9275"
"GO:0002224~toll-like receptor signaling pathway",0.0222222222222222,42.0008300284635,38.4892787524366,0.0256755377211857,0.0587741021894864,"3654"
"GO:0030279~negative regulation of ossification",0.0222222222222222,42.0008300284635,38.4892787524366,0.0256755377211857,0.0587741021894864,"4851"
"GO:2000819~regulation of nucleotide-excision repair",0.0222222222222222,42.0008300284635,38.4892787524366,0.0256755377211857,0.0587741021894864,"9275"
"GO:0034237~protein kinase A regulatory subunit binding",0.0222222222222222,42.0008300284635,38.4892787524366,0.0256755377211857,0.0587741021894864,"10163"
"R-HSA-912526~Interleukin receptor SHC signaling",0.0222222222222222,42.0008300284635,38.4892787524366,0.0256755377211857,0.0587741021894864,"6654"
"R-HSA-354192~Integrin signaling",0.0222222222222222,42.0008300284635,38.4892787524366,0.0256755377211857,0.0587741021894864,"6654"
"WP3845:Canonical and non canonical Notch signaling",0.0222222222222222,42.0008300284635,38.4892787524366,0.0256755377211857,0.0587741021894864,"4851"
"WP195:IL1 signaling",0.028169014084507,44.4187036525649,38.4892787524366,0.0012184766976156,0.035213976561091,"3654, 8878"
"GO:0035924~cellular response to vascular endothelial growth factor stimulus",0.0217391304347826,40.4318435302914,37.1146616541353,0.0266143836884892,0.0595091441854808,"4851"
"GO:0045742~positive regulation of epidermal growth factor receptor signaling pathway",0.0217391304347826,40.4318435302914,37.1146616541353,0.0266143836884892,0.0595091441854808,"6654"
"GO:0060349~bone morphogenesis",0.0217391304347826,40.4318435302914,37.1146616541353,0.0266143836884892,0.0595091441854808,"79065"
"GO:0045662~negative regulation of myoblast differentiation",0.0217391304347826,40.4318435302914,37.1146616541353,0.0266143836884892,0.0595091441854808,"4851"
"GO:0035116~embryonic hindlimb morphogenesis",0.0217391304347826,40.4318435302914,37.1146616541353,0.0266143836884892,0.0595091441854808,"4851"
"GO:0010971~positive regulation of G2/M transition of mitotic cell cycle",0.0217391304347826,40.4318435302914,37.1146616541353,0.0266143836884892,0.0595091441854808,"595"
"R-HSA-5654696~Downstream signaling of activated FGFR2",0.0217391304347826,40.4318435302914,37.1146616541353,0.0266143836884892,0.0595091441854808,"6654"
"R-HSA-9682385~FLT3 signaling in disease",0.0217391304347826,40.4318435302914,37.1146616541353,0.0266143836884892,0.0595091441854808,"6654"
"WP3851:TLR4 signaling and tolerance",0.0217391304347826,40.4318435302914,37.1146616541353,0.0266143836884892,0.0595091441854808,"3654"
"WP2643:Nanoparticle mediated activation of receptor signaling",0.0217391304347826,40.4318435302914,37.1146616541353,0.0266143836884892,0.0595091441854808,"6654"
"WP2361:Gastric cancer network 1",0.0217391304347826,40.4318435302914,37.1146616541353,0.0266143836884892,0.0595091441854808,"4851"
"WP5036:Angiotensin II receptor type 1 pathway",0.0217391304347826,40.4318435302914,37.1146616541353,0.0266143836884892,0.0595091441854808,"1490"
"GO:0010592~positive regulation of lamellipodium assembly",0.0212765957446809,39.0379693983315,35.8348457350272,0.0275523725666106,0.0607834784103088,"10163"
"GO:0051497~negative regulation of stress fiber assembly",0.0212765957446809,39.0379693983315,35.8348457350272,0.0275523725666106,0.0607834784103088,"10163"
"R-HSA-8878159~Transcriptional regulation by RUNX3",0.029126213592233,43.7776882195391,35.8348457350272,7.60806184801681e-05,0.00977213277367493,"1490, 4851, 595"
"R-HSA-5654687~Downstream signaling of activated FGFR1",0.0212765957446809,39.0379693983315,35.8348457350272,0.0275523725666106,0.0607834784103088,"6654"
"R-HSA-2424491~DAP12 signaling",0.0212765957446809,39.0379693983315,35.8348457350272,0.0275523725666106,0.0607834784103088,"6654"
"R-HSA-186763~Downstream signal transduction",0.0212765957446809,39.0379693983315,35.8348457350272,0.0275523725666106,0.0607834784103088,"6654"
"WP3972:PDGFR beta pathway",0.0212765957446809,39.0379693983315,35.8348457350272,0.0275523725666106,0.0607834784103088,"6654"
"hsa05213_Endometrial_cancer",0.0263157894736842,40.5347400939098,35.2274754683318,0.0014527237525142,0.0358506144328846,"595, 6654"
"GO:0045070~positive regulation of viral genome replication",0.0208333333333333,37.6754950202247,34.640350877193,0.0284895050945696,0.0620223500740536,"4851"
"GO:0034142~toll-like receptor 4 signaling pathway",0.0208333333333333,37.6754950202247,34.640350877193,0.0284895050945696,0.0620223500740536,"3654"
"GO:0008089~anterograde axonal transport",0.0208333333333333,37.6754950202247,34.640350877193,0.0284895050945696,0.0620223500740536,"9371"
"GO:0035255~ionotropic glutamate receptor binding",0.0208333333333333,37.6754950202247,34.640350877193,0.0284895050945696,0.0620223500740536,"8878"
"GO:0036094~small molecule binding",0.0208333333333333,37.6754950202247,34.640350877193,0.0284895050945696,0.0620223500740536,"4144"
"WP5365:4p16 3 copy number variation",0.0208333333333333,37.6754950202247,34.640350877193,0.0284895050945696,0.0620223500740536,"6654"
"WP4923:Autophagy",0.0208333333333333,37.6754950202247,34.640350877193,0.0284895050945696,0.0620223500740536,"79065"
"GO:0097421~liver regeneration",0.0204081632653061,36.41492877906,33.5229202037351,0.0294257820107859,0.06264494291799,"595"
"GO:0071345~cellular response to cytokine stimulus",0.0204081632653061,36.41492877906,33.5229202037351,0.0294257820107859,0.06264494291799,"3654"
"GO:0016538~cyclin-dependent protein serine/threonine kinase regulator activity",0.0204081632653061,36.41492877906,33.5229202037351,0.0294257820107859,0.06264494291799,"595"
"R-HSA-399721~Glutamate binding, activation of AMPA receptors and synaptic plasticity",0.0204081632653061,36.41492877906,33.5229202037351,0.0294257820107859,0.06264494291799,"4646"
"R-HSA-399719~Trafficking of AMPA receptors",0.0204081632653061,36.41492877906,33.5229202037351,0.0294257820107859,0.06264494291799,"4646"
"R-HSA-2122948~Activated NOTCH1 Transmits Signal to the Nucleus",0.0204081632653061,36.41492877906,33.5229202037351,0.0294257820107859,0.06264494291799,"4851"
"R-HSA-2871796~FCERI mediated MAPK activation",0.0204081632653061,36.41492877906,33.5229202037351,0.0294257820107859,0.06264494291799,"6654"
"R-HSA-350054~Notch-HLH transcription pathway",0.0204081632653061,36.41492877906,33.5229202037351,0.0294257820107859,0.06264494291799,"4851"
"R-HSA-9680350~Signaling by CSF1 (M-CSF) in myeloid cells",0.0204081632653061,36.41492877906,33.5229202037351,0.0294257820107859,0.06264494291799,"6654"
"WP3858:Toll like receptor signaling related to MyD88",0.0204081632653061,36.41492877906,33.5229202037351,0.0294257820107859,0.06264494291799,"3654"
"WP5180:DYRK1A involvement regarding cell proliferation in brain development",0.0253164556962025,38.4976602371497,33.5229202037351,0.00160279478672997,0.0358506144328846,"4851, 595"
"WP4155:Endometrial cancer",0.025,37.8595060462932,32.9908103592314,0.00165439715468216,0.0358506144328846,"595, 6654"
"GO:0033554~cellular response to stress",0.02,35.2525286927493,32.4753289473684,0.0303612040530801,0.0634675440964929,"8878"
"GO:0071897~DNA biosynthetic process",0.02,35.2525286927493,32.4753289473684,0.0303612040530801,0.0634675440964929,"1490"
"GO:0021915~neural tube development",0.02,35.2525286927493,32.4753289473684,0.0303612040530801,0.0634675440964929,"4851"
"R-HSA-2871809~FCERI mediated Ca+2 mobilization",0.02,35.2525286927493,32.4753289473684,0.0303612040530801,0.0634675440964929,"6654"
"R-HSA-983695~Antigen activates B Cell Receptor (BCR) leading to generation of second messengers",0.02,35.2525286927493,32.4753289473684,0.0303612040530801,0.0634675440964929,"6654"
"KW-0195~Cyclin",0.02,35.2525286927493,32.4753289473684,0.0303612040530801,0.0634675440964929,"595"
"WP2839:Hair follicle development organogenesis part 2 of 3",0.02,35.2525286927493,32.4753289473684,0.0303612040530801,0.0634675440964929,"595"
"WP5312:Metabolic pathways of fibroblasts",0.02,35.2525286927493,32.4753289473684,0.0303612040530801,0.0634675440964929,"2744"
"hsa01522_Endocrine_resistance",0.0267857142857143,39.5643246911072,32.4753289473684,0.000101996116608389,0.00993839565762732,"4851, 595, 6654"
"hsa04136_Autophagy",0.02,35.2525286927493,32.4753289473684,0.0303612040530801,0.0634675440964929,"79065"
"GO:0006730~one-carbon metabolic process",0.0196078431372549,34.1336557929938,31.4912280701754,0.0312957719586749,0.0646034149718361,"4144"
"GO:0070555~response to interleukin-1",0.0196078431372549,34.1336557929938,31.4912280701754,0.0312957719586749,0.0646034149718361,"3654"
"R-HSA-193704~p75 NTR receptor-mediated signalling",0.0260869565217391,38.2765503778462,31.4912280701754,0.00011176396500792,0.00993839565762732,"3654, 6654, 8878"
"R-HSA-187687~Signalling to ERKs",0.0196078431372549,34.1336557929938,31.4912280701754,0.0312957719586749,0.0646034149718361,"6654"
"WP422:MAPK cascade",0.0196078431372549,34.1336557929938,31.4912280701754,0.0312957719586749,0.0646034149718361,"6654"
"WP3676:BDNF TrkB signaling",0.0196078431372549,34.1336557929938,31.4912280701754,0.0312957719586749,0.0646034149718361,"6654"
"WP244:Alpha 6 beta 4 signaling",0.0196078431372549,34.1336557929938,31.4912280701754,0.0312957719586749,0.0646034149718361,"6654"
"WP4496:Signal transduction through IL1R",0.0196078431372549,34.1336557929938,31.4912280701754,0.0312957719586749,0.0646034149718361,"3654"
"GO:0007368~determination of left/right symmetry",0.0238095238095238,35.5307593988407,31.0212097407698,0.00186866269838909,0.0358506144328846,"4851, 9371"
"GO:0002931~response to ischemia",0.0238095238095238,35.5307593988407,31.0212097407698,0.00186866269838909,0.0358506144328846,"6654, 8878"
"GO:0042073~intraciliary transport",0.0192307692307692,33.0942791023894,30.5650154798762,0.0322294864641942,0.0660590183556889,"9371"
"GO:0030071~regulation of mitotic metaphase/anaphase transition",0.0192307692307692,33.0942791023894,30.5650154798762,0.0322294864641942,0.0660590183556889,"9275"
"WP313:Hepatocyte growth factor receptor signaling",0.0192307692307692,33.0942791023894,30.5650154798762,0.0322294864641942,0.0660590183556889,"6654"
"WP4685:Melanoma",0.0235294117647059,34.9831499374894,30.5650154798762,0.00192418611341119,0.0358506144328846,"595, 6654"
"hsa05221_Acute_myeloid_leukemia",0.0235294117647059,34.9831499374894,30.5650154798762,0.00192418611341119,0.0358506144328846,"595, 6654"
"WP5293:Acute myeloid leukemia",0.0232558139534884,34.4418944120455,30.1220442410374,0.00198048955054383,0.0358506144328846,"595, 6654"
"GO:0002040~sprouting angiogenesis",0.0188679245283019,32.1373990964702,29.6917293233083,0.0331623483056621,0.0670714339467148,"4851"
"GO:0031069~hair follicle morphogenesis",0.0188679245283019,32.1373990964702,29.6917293233083,0.0331623483056621,0.0670714339467148,"4851"
"R-HSA-9706574~RHOBTB GTPase Cycle",0.0188679245283019,32.1373990964702,29.6917293233083,0.0331623483056621,0.0670714339467148,"4646"
"WP3617:Photodynamic therapy induced NF kB survival signaling",0.0188679245283019,32.1373990964702,29.6917293233083,0.0331623483056621,0.0670714339467148,"595"
"WP4844:Influence of laminopathies on Wnt signaling",0.0188679245283019,32.1373990964702,29.6917293233083,0.0331623483056621,0.0670714339467148,"595"
"WP3298:Melatonin metabolism and effects",0.0188679245283019,32.1373990964702,29.6917293233083,0.0331623483056621,0.0670714339467148,"3654"
"GO:0001947~heart looping",0.0227272727272727,33.4676151308737,29.2735359525574,0.00209543092582946,0.0358506144328846,"4851, 9645"
"hsa04917_Prolactin_signaling_pathway",0.0227272727272727,33.4676151308737,29.2735359525574,0.00209543092582946,0.0358506144328846,"595, 6654"
"GO:0030330~DNA damage response, signal transduction by p53 class mediator",0.0185185185185185,31.2117296416696,28.8669590643275,0.0340943582185079,0.0676039075481907,"4646"
"GO:0072593~reactive oxygen species metabolic process",0.0185185185185185,31.2117296416696,28.8669590643275,0.0340943582185079,0.0676039075481907,"1490"
"GO:0048873~homeostasis of number of cells within a tissue",0.0185185185185185,31.2117296416696,28.8669590643275,0.0340943582185079,0.0676039075481907,"4851"
"GO:0060412~ventricular septum morphogenesis",0.0185185185185185,31.2117296416696,28.8669590643275,0.0340943582185079,0.0676039075481907,"4851"
"GO:0030032~lamellipodium assembly",0.0185185185185185,31.2117296416696,28.8669590643275,0.0340943582185079,0.0676039075481907,"10163"
"GO:0043122~regulation of canonical NF-kappaB signal transduction",0.0185185185185185,31.2117296416696,28.8669590643275,0.0340943582185079,0.0676039075481907,"8878"
"GO:0031663~lipopolysaccharide-mediated signaling pathway",0.0185185185185185,31.2117296416696,28.8669590643275,0.0340943582185079,0.0676039075481907,"3654"
"GO:0140311~protein sequestering activity",0.0185185185185185,31.2117296416696,28.8669590643275,0.0340943582185079,0.0676039075481907,"8878"
"GO:0005154~epidermal growth factor receptor binding",0.0185185185185185,31.2117296416696,28.8669590643275,0.0340943582185079,0.0676039075481907,"6654"
"R-HSA-5663213~RHO GTPases Activate WASPs and WAVEs",0.0185185185185185,31.2117296416696,28.8669590643275,0.0340943582185079,0.0676039075481907,"10163"
"R-HSA-9687139~Aberrant regulation of mitotic cell cycle due to RB1 defects",0.0185185185185185,31.2117296416696,28.8669590643275,0.0340943582185079,0.0676039075481907,"595"
"WP4255:Non small cell lung cancer",0.0224719101123595,32.9887069784617,28.8669590643275,0.00215406608561393,0.0358506144328846,"595, 6654"
"WP4674:Head and neck squamous cell carcinoma",0.0222222222222222,32.5233720007478,28.4715212689257,0.00221347571076836,0.0358506144328846,"4851, 595"
"hsa05223_Non-small_cell_lung_cancer",0.0222222222222222,32.5233720007478,28.4715212689257,0.00221347571076836,0.0358506144328846,"595, 6654"
"GO:0031100~animal organ regeneration",0.0181818181818182,30.3452631337064,28.0867709815078,0.0350255169375634,0.0679353986238646,"4851"
"GO:0007249~canonical NF-kappaB signal transduction",0.0181818181818182,30.3452631337064,28.0867709815078,0.0350255169375634,0.0679353986238646,"3654"
"GO:0002052~positive regulation of neuroblast proliferation",0.0181818181818182,30.3452631337064,28.0867709815078,0.0350255169375634,0.0679353986238646,"4851"
"GO:0048709~oligodendrocyte differentiation",0.0181818181818182,30.3452631337064,28.0867709815078,0.0350255169375634,0.0679353986238646,"4851"
"GO:0003180~aortic valve morphogenesis",0.0181818181818182,30.3452631337064,28.0867709815078,0.0350255169375634,0.0679353986238646,"4851"
"R-HSA-168638~NOD1/2 Signaling Pathway",0.0181818181818182,30.3452631337064,28.0867709815078,0.0350255169375634,0.0679353986238646,"3654"
"WP127:IL5 signaling",0.0181818181818182,30.3452631337064,28.0867709815078,0.0350255169375634,0.0679353986238646,"6654"
"WP5269:Genetic causes of porto sinusoidal vascular disease",0.0181818181818182,30.3452631337064,28.0867709815078,0.0350255169375634,0.0679353986238646,"4851"
"WP49:IL2 signaling",0.0181818181818182,30.3452631337064,28.0867709815078,0.0350255169375634,0.0679353986238646,"6654"
"WP4329:miRNA role in immune response in sepsis",0.0181818181818182,30.3452631337064,28.0867709815078,0.0350255169375634,0.0679353986238646,"3654"
"WP4331:Neovascularization processes",0.0181818181818182,30.3452631337064,28.0867709815078,0.0350255169375634,0.0679353986238646,"4851"
"hsa00250_Alanine,_aspartate_and_glutamate_metabolism",0.0181818181818182,30.3452631337064,28.0867709815078,0.0350255169375634,0.0679353986238646,"2744"
"hsa05216_Thyroid_cancer",0.0181818181818182,30.3452631337064,28.0867709815078,0.0350255169375634,0.0679353986238646,"595"
"GO:0032481~positive regulation of type I interferon production",0.0178571428571429,29.5261556366717,27.3476454293629,0.0359558251970604,0.0687023701285981,"3654"
"GO:0030163~protein catabolic process",0.021505376344086,31.203417355221,27.3476454293629,0.00239633753794189,0.0358506144328846,"4851, 8878"
"GO:0000146~microfilament motor activity",0.0178571428571429,29.5261556366717,27.3476454293629,0.0359558251970604,0.0687023701285981,"4646"
"R-HSA-9675126~Diseases of mitotic cell cycle",0.0178571428571429,29.5261556366717,27.3476454293629,0.0359558251970604,0.0687023701285981,"595"
"R-HSA-5655302~Signaling by FGFR1 in disease",0.0178571428571429,29.5261556366717,27.3476454293629,0.0359558251970604,0.0687023701285981,"6654"
"R-HSA-5654741~Signaling by FGFR3",0.0178571428571429,29.5261556366717,27.3476454293629,0.0359558251970604,0.0687023701285981,"6654"
"R-HSA-9607240~FLT3 Signaling",0.0178571428571429,29.5261556366717,27.3476454293629,0.0359558251970604,0.0687023701285981,"6654"
"WP5215:Targeted agents in triple negative breast cancer",0.0178571428571429,29.5261556366717,27.3476454293629,0.0359558251970604,0.0687023701285981,"6654"
"WP5497:Cyclin dependent kinase 4 6 inhibitors in breast cancer",0.0178571428571429,29.5261556366717,27.3476454293629,0.0359558251970604,0.0687023701285981,"595"
"hsa00670_One_carbon_pool_by_folate",0.0178571428571429,29.5261556366717,27.3476454293629,0.0359558251970604,0.0687023701285981,"4144"
"hsa05214_Glioma",0.021505376344086,31.203417355221,27.3476454293629,0.00239633753794189,0.0358506144328846,"595, 6654"
"R-HSA-204998~Cell death signalling via NRAGE, NRIF and NADE",0.0212765957446809,30.7871038703811,26.9924812030075,0.00245883119260231,0.0358506144328846,"6654, 8878"
"hsa05220_Chronic_myeloid_leukemia",0.0212765957446809,30.7871038703811,26.9924812030075,0.00245883119260231,0.0358506144328846,"595, 6654"
"GO:0007595~lactation",0.0175438596491228,28.7506765243185,26.6464237516869,0.0368852837306404,0.0696722026023207,"595"
"GO:0043531~ADP binding",0.0175438596491228,28.7506765243185,26.6464237516869,0.0368852837306404,0.0696722026023207,"4646"
"R-HSA-76009~Platelet Aggregation (Plug Formation)",0.0175438596491228,28.7506765243185,26.6464237516869,0.0368852837306404,0.0696722026023207,"6654"
"R-HSA-5654743~Signaling by FGFR4",0.0175438596491228,28.7506765243185,26.6464237516869,0.0368852837306404,0.0696722026023207,"6654"
"R-HSA-75815~Ubiquitin-dependent degradation of Cyclin D",0.0175438596491228,28.7506765243185,26.6464237516869,0.0368852837306404,0.0696722026023207,"595"
"R-HSA-8853884~Transcriptional Regulation by VENTX",0.0175438596491228,28.7506765243185,26.6464237516869,0.0368852837306404,0.0696722026023207,"595"
"GO:0007032~endosome organization",0.0172413793103448,28.0153977527587,25.9802631578947,0.0378138932713445,0.0709624360741466,"8878"
"R-HSA-8853659~RET signaling",0.0172413793103448,28.0153977527587,25.9802631578947,0.0378138932713445,0.0709624360741466,"6654"
"WP2526:PDGF pathway",0.0172413793103448,28.0153977527587,25.9802631578947,0.0378138932713445,0.0709624360741466,"6654"
"WP2828:Bladder cancer",0.0172413793103448,28.0153977527587,25.9802631578947,0.0378138932713445,0.0709624360741466,"595"
"WP5205:Clock controlled autophagy in bone metabolism",0.0206185567010309,29.6027309703832,25.9802631578947,0.00265091200023971,0.0358506144328846,"4851, 8878"
"hsa05206_MicroRNAs_in_cancer",0.0224719101123595,32.779796683301,25.5020988052954,1.57504360902904e-05,0.00707446454368608,"2744, 4851, 595, 6654"
"GO:0050853~B cell receptor signaling pathway",0.0169491525423729,27.3171815224693,25.3465982028241,0.038741654551621,0.0716565642586783,"6654"
"GO:0030513~positive regulation of BMP signaling pathway",0.0169491525423729,27.3171815224693,25.3465982028241,0.038741654551621,0.0716565642586783,"4851"
"GO:1900087~positive regulation of G1/S transition of mitotic cell cycle",0.0169491525423729,27.3171815224693,25.3465982028241,0.038741654551621,0.0716565642586783,"595"
"GO:0046427~positive regulation of receptor signaling pathway via JAK-STAT",0.0169491525423729,27.3171815224693,25.3465982028241,0.038741654551621,0.0716565642586783,"4851"
"GO:0032467~positive regulation of cytokinesis",0.0169491525423729,27.3171815224693,25.3465982028241,0.038741654551621,0.0716565642586783,"9371"
"GO:0071949~FAD binding",0.0169491525423729,27.3171815224693,25.3465982028241,0.038741654551621,0.0716565642586783,"9645"
"GO:0042169~SH2 domain binding",0.0169491525423729,27.3171815224693,25.3465982028241,0.038741654551621,0.0716565642586783,"8878"
"R-HSA-186712~Regulation of beta-cell development",0.0169491525423729,27.3171815224693,25.3465982028241,0.038741654551621,0.0716565642586783,"4851"
"hsa05219_Bladder_cancer",0.0169491525423729,27.3171815224693,25.3465982028241,0.038741654551621,0.0716565642586783,"595"
"GO:0030324~lung development",0.02,28.5065893580517,25.0412175015853,0.00284986372289279,0.0358506144328846,"1490, 4851"
"R-HSA-9824585~Regulation of MITF-M-dependent genes involved in pigmentation",0.0166666666666667,26.6531690698603,24.7431077694236,0.0396685683033218,0.0729043958006995,"9275"
"R-HSA-1433557~Signaling by SCF-KIT",0.0166666666666667,26.6531690698603,24.7431077694236,0.0396685683033218,0.0729043958006995,"6654"
"R-HSA-9013420~RHOU GTPase cycle",0.0166666666666667,26.6531690698603,24.7431077694236,0.0396685683033218,0.0729043958006995,"4646"
"WP4806:EGFR tyrosine kinase inhibitor resistance",0.0198019801980198,28.1590743118542,24.7431077694236,0.00291770143839793,0.0358815198168937,"595, 6654"
"WP4290:Metabolic reprogramming in colon cancer",0.0166666666666667,26.6531690698603,24.7431077694236,0.0396685683033218,0.0729043958006995,"2744"
"WP4298:Acute viral myocarditis",0.0196078431372549,27.8199285288353,24.4520123839009,0.00298629711279227,0.0361256119250341,"595, 6654"
"GO:0001942~hair follicle development",0.0163934426229508,26.0207669272888,24.1676866585067,0.0405946352577065,0.073901414736864,"6654"
"R-HSA-9759194~Nuclear events mediated by NFE2L2",0.0194174757281553,27.4888384741914,24.1676866585067,0.00305564938155824,0.0361256119250341,"4851, 8878"
"R-HSA-5655253~Signaling by FGFR2 in disease",0.0163934426229508,26.0207669272888,24.1676866585067,0.0405946352577065,0.073901414736864,"6654"
"WP364:IL6 signaling",0.0163934426229508,26.0207669272888,24.1676866585067,0.0405946352577065,0.073901414736864,"6654"
"WP4249:Hedgehog signaling",0.0163934426229508,26.0207669272888,24.1676866585067,0.0405946352577065,0.073901414736864,"595"
"WP4136:Fibrin complement receptor 3 signaling",0.0163934426229508,26.0207669272888,24.1676866585067,0.0405946352577065,0.073901414736864,"3654"
"WP2840:Hair follicle development cytodifferentiation stage 3 of 3",0.0192307692307692,27.1655060345297,23.8898971566848,0.00312575688186595,0.0361256119250341,"1490, 4851"
"hsa05210_Colorectal_cancer",0.0192307692307692,27.1655060345297,23.8898971566848,0.00312575688186595,0.0361256119250341,"595, 6654"
"R-HSA-451927~Interleukin-2 family signaling",0.0161290322580645,25.4176301872469,23.6184210526316,0.041519856145439,0.0751126036058332,"6654"
"WP2817:Mammary gland development pregnancy and lactation stage 3 of 4",0.0161290322580645,25.4176301872469,23.6184210526316,0.041519856145439,0.0751126036058332,"595"
"WP1591:Heart development",0.0161290322580645,25.4176301872469,23.6184210526316,0.041519856145439,0.0751126036058332,"4851"
"WP5098:T cell activation SARS CoV 2",0.019047619047619,26.8496478293803,23.6184210526316,0.00319661825257148,0.0361256119250341,"595, 6654"
"R-HSA-445989~TAK1-dependent IKK and NF-kappa-B activation  ",0.0158730158730159,24.8274080572213,23.093567251462,0.0424442316965903,0.0763072034856273,"3654"
"R-HSA-9824272~Somitogenesis",0.0158730158730159,24.8274080572213,23.093567251462,0.0424442316965903,0.0763072034856273,"4851"
"WP268:Notch signaling",0.0158730158730159,24.8274080572213,23.093567251462,0.0424442316965903,0.0763072034856273,"4851"
"WP673:ErbB signaling",0.0186915887850467,26.2397123697544,23.093567251462,0.00334059716901961,0.0361256119250341,"595, 6654"
"WP5493:Effect of dasatinib on the BCR ABL signaling pathway",0.0158730158730159,24.8274080572213,23.093567251462,0.0424442316965903,0.0763072034856273,"6654"
"R-HSA-9663891~Selective autophagy",0.0185185185185185,25.9437681845916,22.8397917871602,0.00341371200088856,0.0361256119250341,"79065, 8878"
"R-HSA-69236~G1 Phase",0.015625,24.2752789310269,22.591533180778,0.0433677626406396,0.0776054699885129,"595"
"R-HSA-69231~Cyclin D associated events in G1",0.015625,24.2752789310269,22.591533180778,0.0433677626406396,0.0776054699885129,"595"
"R-HSA-112399~IRS-mediated signalling",0.015625,24.2752789310269,22.591533180778,0.0433677626406396,0.0776054699885129,"6654"
"WP4746:Thyroid hormones production and peripheral downstream signaling effects",0.0181818181818182,25.3718401269713,22.3486134691568,0.00356218563982751,0.0361256119250341,"4851, 6654"
"GO:0090307~mitotic spindle assembly",0.0153846153846154,23.747833080242,22.1108622620381,0.0442904497064712,0.0785272390501238,"9371"
"GO:1902459~positive regulation of stem cell population maintenance",0.0153846153846154,23.747833080242,22.1108622620381,0.0442904497064712,0.0785272390501238,"9275"
"GO:0035914~skeletal muscle cell differentiation",0.0153846153846154,23.747833080242,22.1108622620381,0.0442904497064712,0.0785272390501238,"4851"
"GO:2000781~positive regulation of double-strand break repair",0.0153846153846154,23.747833080242,22.1108622620381,0.0442904497064712,0.0785272390501238,"9275"
"R-HSA-2122947~NOTCH1 Intracellular Domain Regulates Transcription",0.0153846153846154,23.747833080242,22.1108622620381,0.0442904497064712,0.0785272390501238,"4851"
"WP363:Wnt signaling",0.0153846153846154,23.747833080242,22.1108622620381,0.0442904497064712,0.0785272390501238,"595"
"GO:0045747~positive regulation of Notch signaling pathway",0.0151515151515152,23.243338683891,21.6502192982456,0.0452122936223809,0.0793101842602008,"4851"
"GO:0120163~negative regulation of cold-induced thermogenesis",0.0151515151515152,23.243338683891,21.6502192982456,0.0452122936223809,0.0793101842602008,"4851"
"GO:0004857~enzyme inhibitor activity",0.0151515151515152,23.243338683891,21.6502192982456,0.0452122936223809,0.0793101842602008,"4851"
"GO:0003774~cytoskeletal motor activity",0.0151515151515152,23.243338683891,21.6502192982456,0.0452122936223809,0.0793101842602008,"4646"
"R-HSA-9012852~Signaling by NOTCH3",0.0151515151515152,23.243338683891,21.6502192982456,0.0452122936223809,0.0793101842602008,"4851"
"WP2848:Pluripotent stem cell differentiation pathway",0.0151515151515152,23.243338683891,21.6502192982456,0.0452122936223809,0.0793101842602008,"4851"
"WP5053:Development of ureteric derived collecting system",0.0151515151515152,23.243338683891,21.6502192982456,0.0452122936223809,0.0793101842602008,"595"
"GO:0060337~type I interferon-mediated signaling pathway",0.0149253731343284,22.7602120334824,21.2083780880773,0.0461332951160683,0.0803163993285768,"3654"
"R-HSA-512988~Interleukin-3, Interleukin-5 and GM-CSF signaling",0.0149253731343284,22.7602120334824,21.2083780880773,0.0461332951160683,0.0803163993285768,"6654"
"R-HSA-5654736~Signaling by FGFR1",0.0149253731343284,22.7602120334824,21.2083780880773,0.0461332951160683,0.0803163993285768,"6654"
"WP286:IL3 signaling",0.0149253731343284,22.7602120334824,21.2083780880773,0.0461332951160683,0.0803163993285768,"6654"
"WP2637:Interleukin 1 IL 1 structural pathway",0.0149253731343284,22.7602120334824,21.2083780880773,0.0461332951160683,0.0803163993285768,"3654"
"WP5475:Hallmark of cancer sustaining proliferative signaling",0.0173913043478261,24.0480384929298,21.2083780880773,0.00394639658184181,0.036496275588873,"595, 6654"
"hsa05215_Prostate_cancer",0.0173913043478261,24.0480384929298,21.2083780880773,0.00394639658184181,0.036496275588873,"595, 6654"
"hsa05224_Breast_cancer",0.0182926829268293,25.2800474808982,21.0650782361309,0.000366153062675052,0.0235437950857276,"4851, 595, 6654"
"R-HSA-1912408~Pre-NOTCH Transcription and Translation",0.0172413793103448,23.7998366739279,20.9941520467836,0.00402546117187962,0.0366412056275027,"4851, 595"
"hsa05231_Choline_metabolism_in_cancer",0.0172413793103448,23.7998366739279,20.9941520467836,0.00402546117187962,0.0366412056275027,"10163, 6654"
"GO:0003151~outflow tract morphogenesis",0.0147058823529412,22.2896829048926,20.7842105263158,0.0470534549146466,0.0805833983427133,"4851"
"R-HSA-187577~SCF(Skp2)-mediated degradation of p27/p21",0.0147058823529412,22.2896829048926,20.7842105263158,0.0470534549146466,0.0805833983427133,"595"
"R-HSA-1227986~Signaling by ERBB2",0.0147058823529412,22.2896829048926,20.7842105263158,0.0470534549146466,0.0805833983427133,"6654"
"R-HSA-2428924~IGF1R signaling cascade",0.0147058823529412,22.2896829048926,20.7842105263158,0.0470534549146466,0.0805833983427133,"6654"
"R-HSA-2428928~IRS-related events triggered by IGF1R",0.0147058823529412,22.2896829048926,20.7842105263158,0.0470534549146466,0.0805833983427133,"6654"
"KW-1009~Hearing",0.0147058823529412,22.2896829048926,20.7842105263158,0.0470534549146466,0.0805833983427133,"4646"
"WP395:IL4 signaling",0.0147058823529412,22.2896829048926,20.7842105263158,0.0470534549146466,0.0805833983427133,"6654"
"WP2018:RANKL RANK signaling",0.0147058823529412,22.2896829048926,20.7842105263158,0.0470534549146466,0.0805833983427133,"8878"
"WP5373:Osteoarthritic chondrocyte hypertrophy",0.0147058823529412,22.2896829048926,20.7842105263158,0.0470534549146466,0.0805833983427133,"1490"
"GO:0050673~epithelial cell proliferation",0.0144927536231884,21.8433714921843,20.3766769865841,0.0479727737446354,0.0811954999250344,"4851"
"GO:0008543~fibroblast growth factor receptor signaling pathway",0.0168067226890756,23.0526599603879,20.3766769865841,0.00426707559140829,0.0382382897958758,"1490, 6654"
"GO:0034605~cellular response to heat",0.0144927536231884,21.8433714921843,20.3766769865841,0.0479727737446354,0.0811954999250344,"3654"
"R-HSA-9020702~Interleukin-1 signaling",0.0168067226890756,23.0526599603879,20.3766769865841,0.00426707559140829,0.0382382897958758,"3654, 8878"
"R-HSA-2172127~DAP12 interactions",0.0144927536231884,21.8433714921843,20.3766769865841,0.0479727737446354,0.0811954999250344,"6654"
"R-HSA-2404192~Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)",0.0144927536231884,21.8433714921843,20.3766769865841,0.0479727737446354,0.0811954999250344,"6654"
"R-HSA-112310~Neurotransmitter release cycle",0.0144927536231884,21.8433714921843,20.3766769865841,0.0479727737446354,0.0811954999250344,"2744"
"KW-0518~Myosin",0.0144927536231884,21.8433714921843,20.3766769865841,0.0479727737446354,0.0811954999250344,"4646"
"WP3286:Copper homeostasis",0.0144927536231884,21.8433714921843,20.3766769865841,0.0479727737446354,0.0811954999250344,"595"
"WP3611:Photodynamic therapy induced AP 1 survival signaling",0.0144927536231884,21.8433714921843,20.3766769865841,0.0479727737446354,0.0811954999250344,"595"
"WP4262:Breast cancer pathway",0.0175438596491228,24.1160112233779,20.1137521222411,0.000419204945025413,0.0235437950857276,"4851, 595, 6654"
"GO:0045668~negative regulation of osteoblast differentiation",0.0142857142857143,21.4144852489338,19.9848178137652,0.0488912523319645,0.0817920227145454,"4851"
"GO:0030900~forebrain development",0.0142857142857143,21.4144852489338,19.9848178137652,0.0488912523319645,0.0817920227145454,"4851"
"GO:0005080~protein kinase C binding",0.0142857142857143,21.4144852489338,19.9848178137652,0.0488912523319645,0.0817920227145454,"8878"
"R-HSA-190828~Gap junction trafficking",0.0142857142857143,21.4144852489338,19.9848178137652,0.0488912523319645,0.0817920227145454,"4646"
"R-HSA-9856651~MITF-M-dependent gene expression",0.0165289256198347,22.6038443955171,19.9848178137652,0.00443182237253893,0.0382881509204268,"595, 9275"
"R-HSA-74751~Insulin receptor signalling cascade",0.0142857142857143,21.4144852489338,19.9848178137652,0.0488912523319645,0.0817920227145454,"6654"
"R-HSA-73887~Death Receptor Signaling",0.0174418604651163,23.9584521199173,19.9848178137652,0.000427164875863729,0.0235437950857276,"3654, 6654, 8878"
"KW-0914~Notch signaling pathway",0.0142857142857143,21.4144852489338,19.9848178137652,0.0488912523319645,0.0817920227145454,"4851"
"WP4747:Netrin UNC5B signaling",0.0142857142857143,21.4144852489338,19.9848178137652,0.0488912523319645,0.0817920227145454,"1490"
"WP4932:7q11 23 copy number variation syndrome",0.0165289256198347,22.6038443955171,19.9848178137652,0.00443182237253893,0.0382881509204268,"8878, 9275"
"hsa00270_Cysteine_and_methionine_metabolism",0.0142857142857143,21.4144852489338,19.9848178137652,0.0488912523319645,0.0817920227145454,"4144"
"hsa04137_Mitophagy",0.0165289256198347,22.6038443955171,19.9848178137652,0.00443182237253893,0.0382881509204268,"79065, 8878"
"GO:0006606~protein import into nucleus",0.0163934426229508,22.3858341639172,19.7944862155388,0.00451529291032809,0.0382881509204268,"4851, 8878"
"GO:0097009~energy homeostasis",0.0140845070422535,20.9917099819563,19.6077457795432,0.0498088914019734,0.0822558263724018,"8878"
"GO:0051496~positive regulation of stress fiber assembly",0.0140845070422535,20.9917099819563,19.6077457795432,0.0498088914019734,0.0822558263724018,"1490"
"GO:0001837~epithelial to mesenchymal transition",0.0140845070422535,20.9917099819563,19.6077457795432,0.0498088914019734,0.0822558263724018,"4851"
"R-HSA-177929~Signaling by EGFR",0.0140845070422535,20.9917099819563,19.6077457795432,0.0498088914019734,0.0822558263724018,"6654"
"WP304:Kit receptor signaling",0.0140845070422535,20.9917099819563,19.6077457795432,0.0498088914019734,0.0822558263724018,"6654"
"WP2864:Apoptosis related network due to altered Notch3 in ovarian cancer",0.0140845070422535,20.9917099819563,19.6077457795432,0.0498088914019734,0.0822558263724018,"8878"
"WP2406:Cardiac progenitor differentiation",0.0140845070422535,20.9917099819563,19.6077457795432,0.0498088914019734,0.0822558263724018,"4851"
"WP5144:NRP1 triggered signaling in pancreatic cancer ",0.0140845070422535,20.9917099819563,19.6077457795432,0.0498088914019734,0.0822558263724018,"1490"
"GO:0048661~positive regulation of smooth muscle cell proliferation",0.0138888888888889,20.5987157375031,19.2446393762183,0.0507256916794139,0.0829404520246145,"3654"
"GO:0007188~adenylate cyclase-modulating G protein-coupled receptor signaling pathway",0.0138888888888889,20.5987157375031,19.2446393762183,0.0507256916794139,0.0829404520246145,"10163"
"R-HSA-8848021~Signaling by PTK6",0.0138888888888889,20.5987157375031,19.2446393762183,0.0507256916794139,0.0829404520246145,"595"
"R-HSA-9006927~Signaling by Non-Receptor Tyrosine Kinases",0.0138888888888889,20.5987157375031,19.2446393762183,0.0507256916794139,0.0829404520246145,"595"
"R-HSA-157858~Gap junction trafficking and regulation",0.0138888888888889,20.5987157375031,19.2446393762183,0.0507256916794139,0.0829404520246145,"4646"
"R-HSA-5620924~Intraflagellar transport",0.0138888888888889,20.5987157375031,19.2446393762183,0.0507256916794139,0.0829404520246145,"9371"
"WP61:Notch signaling",0.0138888888888889,20.5987157375031,19.2446393762183,0.0507256916794139,0.0829404520246145,"4851"
"WP2263:Androgen receptor network in prostate cancer",0.0158730158730159,21.5498208641198,19.0680830516659,0.00485645833680337,0.0384525057352376,"595, 6654"
"GO:0030968~endoplasmic reticulum unfolded protein response",0.0136986301369863,20.2184975656659,18.8947368421053,0.0516416538884479,0.0839630828341009,"595"
"GO:1904263~positive regulation of TORC1 signaling",0.0136986301369863,20.2184975656659,18.8947368421053,0.0516416538884479,0.0839630828341009,"4144"
"WP4874:CAMKK2 pathway",0.015748031496063,21.3498393343631,18.8947368421053,0.00494356387744601,0.0386132421778891,"595, 8878"
"WP4879:Overlap between signal transduction pathways contributing to LMNA laminopathies",0.0136986301369863,20.2184975656659,18.8947368421053,0.0516416538884479,0.0839630828341009,"4851"
"WP710:DNA damage response only ATM dependent ",0.015748031496063,21.3498393343631,18.8947368421053,0.00494356387744601,0.0386132421778891,"595, 6654"
"GO:0042472~inner ear morphogenesis",0.0135135135135135,19.8511580118798,18.5573308270677,0.0525567787526494,0.084500189482702,"4646"
"GO:0002062~chondrocyte differentiation",0.0135135135135135,19.8511580118798,18.5573308270677,0.0525567787526494,0.084500189482702,"1490"
"GO:0031397~negative regulation of protein ubiquitination",0.0135135135135135,19.8511580118798,18.5573308270677,0.0525567787526494,0.084500189482702,"8878"
"GO:0050680~negative regulation of epithelial cell proliferation",0.0135135135135135,19.8511580118798,18.5573308270677,0.0525567787526494,0.084500189482702,"4851"
"R-HSA-9755511~KEAP1-NFE2L2 pathway",0.0155038759689922,20.9509409502713,18.5573308270677,0.00511994271390817,0.0391711933141871,"4851, 8878"
"WP2849:Hematopoietic stem cell differentiation",0.0135135135135135,19.8511580118798,18.5573308270677,0.0525567787526494,0.084500189482702,"4851"
"WP2374:Oncostatin M signaling",0.0135135135135135,19.8511580118798,18.5573308270677,0.0525567787526494,0.084500189482702,"6654"
"WP4754:IL18 signaling",0.0135135135135135,19.8511580118798,18.5573308270677,0.0525567787526494,0.084500189482702,"3654"
"hsa04340_Hedgehog_signaling_pathway",0.0135135135135135,19.8511580118798,18.5573308270677,0.0525567787526494,0.084500189482702,"595"
"GO:1903078~positive regulation of protein localization to plasma membrane",0.0133333333333333,19.4868314819671,18.2317636195753,0.0534710669950029,0.0854945414193961,"8878"
"GO:0007052~mitotic spindle organization",0.0133333333333333,19.4868314819671,18.2317636195753,0.0534710669950029,0.0854945414193961,"9371"
"R-HSA-168643~Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways",0.0133333333333333,19.4868314819671,18.2317636195753,0.0534710669950029,0.0854945414193961,"3654"
"WP5265:Neurogenesis regulation in the olfactory epithelium",0.0133333333333333,19.4868314819671,18.2317636195753,0.0534710669950029,0.0854945414193961,"4851"
"R-HSA-1912422~Pre-NOTCH Expression and Processing",0.0151515151515152,20.4087169481899,18.0732265446224,0.00538991056324809,0.0391711933141871,"4851, 595"
"WP4659:Gastrin signaling",0.0151515151515152,20.4087169481899,18.0732265446224,0.00538991056324809,0.0391711933141871,"595, 6654"
"GO:0003777~microtubule motor activity",0.0131578947368421,19.161122484242,17.9174228675136,0.054384519337907,0.0858859349106837,"9371"
"R-HSA-2894858~Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer",0.0131578947368421,19.161122484242,17.9174228675136,0.054384519337907,0.0858859349106837,"4851"
"R-HSA-186797~Signaling by PDGF",0.0131578947368421,19.161122484242,17.9174228675136,0.054384519337907,0.0858859349106837,"6654"
"R-HSA-1236394~Signaling by ERBB4",0.0131578947368421,19.161122484242,17.9174228675136,0.054384519337907,0.0858859349106837,"6654"
"R-HSA-2644606~Constitutive Signaling by NOTCH1 PEST Domain Mutants",0.0131578947368421,19.161122484242,17.9174228675136,0.054384519337907,0.0858859349106837,"4851"
"R-HSA-2644602~Signaling by NOTCH1 PEST Domain Mutants in Cancer",0.0131578947368421,19.161122484242,17.9174228675136,0.054384519337907,0.0858859349106837,"4851"
"R-HSA-2644603~Signaling by NOTCH1 in Cancer",0.0131578947368421,19.161122484242,17.9174228675136,0.054384519337907,0.0858859349106837,"4851"
"R-HSA-2894862~Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants",0.0131578947368421,19.161122484242,17.9174228675136,0.054384519337907,0.0858859349106837,"4851"
"WP5236:Markers of kidney cell lineage",0.0131578947368421,19.161122484242,17.9174228675136,0.054384519337907,0.0858859349106837,"4851"
"GO:0002376~immune system process",0.012987012987013,18.826681384167,17.6137377341659,0.0552971365031725,0.0866171948477878,"8878"
"R-HSA-9664422~FCGR3A-mediated phagocytosis",0.012987012987013,18.826681384167,17.6137377341659,0.0552971365031725,0.0866171948477878,"10163"
"R-HSA-9664407~Parasite infection",0.012987012987013,18.826681384167,17.6137377341659,0.0552971365031725,0.0866171948477878,"10163"
"R-HSA-9664417~Leishmania phagocytosis",0.012987012987013,18.826681384167,17.6137377341659,0.0552971365031725,0.0866171948477878,"10163"
"R-HSA-9793380~Formation of paraxial mesoderm",0.012987012987013,18.826681384167,17.6137377341659,0.0552971365031725,0.0866171948477878,"4851"
"WP4205:MET in type 1 papillary renal cell carcinoma",0.012987012987013,18.826681384167,17.6137377341659,0.0552971365031725,0.0866171948477878,"6654"
"GO:0017124~SH3 domain binding",0.0147058823529412,19.7025890925404,17.4657231313578,0.00575989169000069,0.0391711933141871,"10163, 6654"
"GO:0030514~negative regulation of BMP signaling pathway",0.0128205128205128,18.5050723137042,17.3201754385965,0.0562089192120229,0.0875707690149575,"4851"
"GO:0045597~positive regulation of cell differentiation",0.0128205128205128,18.5050723137042,17.3201754385965,0.0562089192120229,0.0875707690149575,"1490"
"GO:0031072~heat shock protein binding",0.0128205128205128,18.5050723137042,17.3201754385965,0.0562089192120229,0.0875707690149575,"3654"
"R-HSA-193648~NRAGE signals death through JNK",0.0128205128205128,18.5050723137042,17.3201754385965,0.0562089192120229,0.0875707690149575,"6654"
"WP4541:Hippo Merlin signaling dysregulation",0.0145985401459854,19.534210482466,17.3201754385965,0.00585416822825119,0.0393454562317348,"1490, 595"
"hsa04722_Neurotrophin_signaling_pathway",0.0145985401459854,19.534210482466,17.3201754385965,0.00585416822825119,0.0393454562317348,"3654, 6654"
"GO:0045596~negative regulation of cell differentiation",0.0126582278481013,18.1950606613915,17.0362381363244,0.057119868185098,0.0887507629327597,"9275"
"R-HSA-375165~NCAM signaling for neurite out-growth",0.0126582278481013,18.1950606613915,17.0362381363244,0.057119868185098,0.0887507629327597,"6654"
"hsa04919_Thyroid_hormone_signaling_pathway",0.0143884892086331,19.2062944396459,17.0362381363244,0.0060448496616487,0.040392174617722,"4851, 595"
"GO:0000987~cis-regulatory region sequence-specific DNA binding",0.0125,17.8956976758392,16.7614601018676,0.0580299841424482,0.0896827027656018,"4851"
"R-HSA-2029482~Regulation of actin dynamics for phagocytic cup formation",0.0125,17.8956976758392,16.7614601018676,0.0580299841424482,0.0896827027656018,"10163"
"WP3863:T cell antigen receptor TCR pathway during Staphylococcus aureus infection",0.0125,17.8956976758392,16.7614601018676,0.0580299841424482,0.0896827027656018,"6654"
"hsa04330_Notch_signaling_pathway",0.0125,17.8956976758392,16.7614601018676,0.0580299841424482,0.0896827027656018,"4851"
"GO:0006959~humoral immune response",0.0123456790123457,17.6062356742035,16.4954051796157,0.0589392678035409,0.0906034489107623,"4851"
"R-HSA-450294~MAP kinase activation",0.0123456790123457,17.6062356742035,16.4954051796157,0.0589392678035409,0.0906034489107623,"3654"
"R-HSA-1226099~Signaling by FGFR in disease",0.0123456790123457,17.6062356742035,16.4954051796157,0.0589392678035409,0.0906034489107623,"6654"
"WP3624:Lung fibrosis",0.0123456790123457,17.6062356742035,16.4954051796157,0.0589392678035409,0.0906034489107623,"1490"
"GO:0016197~endosomal transport",0.0121951219512195,17.331427018499,16.2376644736842,0.0598477198872586,0.0915131801450673,"8878"
"GO:0042552~myelination",0.0121951219512195,17.331427018499,16.2376644736842,0.0598477198872586,0.0915131801450673,"6654"
"R-HSA-8986944~Transcriptional Regulation by MECP2",0.0121951219512195,17.331427018499,16.2376644736842,0.0598477198872586,0.0915131801450673,"3654"
"WP45:G1 to S cell cycle control",0.0121951219512195,17.331427018499,16.2376644736842,0.0598477198872586,0.0915131801450673,"595"
"GO:0030971~receptor tyrosine kinase binding",0.0120481927710843,17.0521828028135,15.9878542510121,0.0607553411118986,0.0923387932277473,"8878"
"R-HSA-983189~Kinesins",0.0120481927710843,17.0521828028135,15.9878542510121,0.0607553411118986,0.0923387932277473,"9371"
"WP3651:Pathways affected in adenoid cystic carcinoma",0.0120481927710843,17.0521828028135,15.9878542510121,0.0607553411118986,0.0923387932277473,"4851"
"GO:0071456~cellular response to hypoxia",0.0135135135135135,17.8583828270125,15.8658095620731,0.00693777644637346,0.0417364463738037,"3654, 4851"
"GO:0051289~protein homotetramerization",0.0119047619047619,16.7915758532851,15.7456140350877,0.0616621321951754,0.0933002942639041,"2744"
"WP366:TGF beta signaling pathway",0.0134228187919463,17.7204953070101,15.7456140350877,0.00704048586918146,0.0417364463738037,"595, 6654"
"WP3680:Physico chemical features and toxicity associated pathways",0.0119047619047619,16.7915758532851,15.7456140350877,0.0616621321951754,0.0933002942639041,"6654"
"WP5417:Cell lineage map for neuronal differentiation",0.0134228187919463,17.7204953070101,15.7456140350877,0.00704048586918146,0.0417364463738037,"2744, 4851"
"hsa04068_FoxO_signaling_pathway",0.0133333333333333,17.5831663499197,15.6272259596359,0.00714388962814395,0.0417364463738037,"595, 6654"
"GO:0030216~keratinocyte differentiation",0.0117647058823529,16.5323139618288,15.5106048703849,0.0625680938542174,0.0944239118739886,"4851"
"GO:0060021~roof of mouth development",0.0117647058823529,16.5323139618288,15.5106048703849,0.0625680938542174,0.0944239118739886,"6654"
"hsa05130_Pathogenic_Escherichia_coli_infection",0.0136986301369863,18.2832149531705,15.3577910292974,0.000918868011572935,0.0317823680497783,"10163, 3654, 4646"
"GO:0004497~monooxygenase activity",0.0116279069767442,16.2915335178205,15.2825077399381,0.0634732268055724,0.0955404299313043,"9645"
"KW-0505~Motor protein",0.0130718954248366,17.1935368136804,15.2825077399381,0.0074582540756697,0.0417364463738037,"4646, 9371"
"WP3303:RAC1 PAK1 p38 MMP2 pathway",0.0116279069767442,16.2915335178205,15.2825077399381,0.0634732268055724,0.0955404299313043,"6654"
"WP4630:Measles virus infection",0.0130718954248366,17.1935368136804,15.2825077399381,0.0074582540756697,0.0417364463738037,"3654, 595"
"GO:0032496~response to lipopolysaccharide",0.0129032258064516,16.9342216231099,15.0610221205187,0.00767127853134716,0.0417364463738037,"3654, 4851"
"GO:0043124~negative regulation of canonical NF-kappaB signal transduction",0.0114942528735632,16.0490059007597,15.0610221205187,0.064377531765205,0.0961504221196085,"3654"
"GO:0043539~protein serine/threonine kinase activator activity",0.0114942528735632,16.0490059007597,15.0610221205187,0.064377531765205,0.0961504221196085,"595"
"WP2525:Trans sulfuration one carbon metabolism and related pathways",0.0114942528735632,16.0490059007597,15.0610221205187,0.064377531765205,0.0961504221196085,"4144"
"WP1530:miRNA regulation of DNA damage response",0.0114942528735632,16.0490059007597,15.0610221205187,0.064377531765205,0.0961504221196085,"595"
"WP707:DNA damage response",0.0114942528735632,16.0490059007597,15.0610221205187,0.064377531765205,0.0961504221196085,"595"
"hsa04664_Fc_epsilon_RI_signaling_pathway",0.0114942528735632,16.0490059007597,15.0610221205187,0.064377531765205,0.0961504221196085,"6654"
"hsa05135_Yersinia_infection",0.0129032258064516,16.9342216231099,15.0610221205187,0.00767127853134716,0.0417364463738037,"10163, 3654"
"hsa04371_Apelin_signaling_pathway",0.0128205128205128,16.8098728254273,14.9526694433927,0.00777882136933379,0.0417364463738037,"1490, 595"
"hsa05162_Measles",0.0128205128205128,16.8098728254273,14.9526694433927,0.00777882136933379,0.0417364463738037,"3654, 595"
"GO:0050679~positive regulation of epithelial cell proliferation",0.0113636363636364,15.8158519876395,14.8458646616541,0.0652810094484975,0.0968740011841631,"4851"
"GO:0042110~T cell activation",0.0113636363636364,15.8158519876395,14.8458646616541,0.0652810094484975,0.0968740011841631,"6654"
"R-HSA-5654738~Signaling by FGFR2",0.0113636363636364,15.8158519876395,14.8458646616541,0.0652810094484975,0.0968740011841631,"6654"
"hsa05211_Renal_cell_carcinoma",0.0113636363636364,15.8158519876395,14.8458646616541,0.0652810094484975,0.0968740011841631,"6654"
"hsa05416_Viral_myocarditis",0.0113636363636364,15.8158519876395,14.8458646616541,0.0652810094484975,0.0968740011841631,"595"
"GO:0032088~negative regulation of NF-kappaB transcription factor activity",0.0112359550561798,15.589409138399,14.6367679762787,0.0661836605702503,0.0973388188539559,"3654"
"GO:0009611~response to wounding",0.0112359550561798,15.589409138399,14.6367679762787,0.0661836605702503,0.0973388188539559,"1490"
"GO:0016236~macroautophagy",0.0112359550561798,15.589409138399,14.6367679762787,0.0661836605702503,0.0973388188539559,"8878"
"GO:0000045~autophagosome assembly",0.0112359550561798,15.589409138399,14.6367679762787,0.0661836605702503,0.0973388188539559,"79065"
"R-HSA-446652~Interleukin-1 family signaling",0.0125786163522013,16.4475391628905,14.6367679762787,0.00810555701885333,0.0417364463738037,"3654, 8878"
"R-HSA-448424~Interleukin-17 signaling",0.0112359550561798,15.589409138399,14.6367679762787,0.0661836605702503,0.0973388188539559,"3654"
"WP2034:Leptin signaling",0.0112359550561798,15.589409138399,14.6367679762787,0.0661836605702503,0.0973388188539559,"6654"
"hsa05230_Central_carbon_metabolism_in_cancer",0.0112359550561798,15.589409138399,14.6367679762787,0.0661836605702503,0.0973388188539559,"2744"
"hsa04936_Alcoholic_liver_disease",0.0125,16.3302101359394,14.5344129554656,0.00821583370512266,0.0417364463738037,"3654, 595"
"R-HSA-3906995~Diseases associated with O-glycosylation of proteins",0.0111111111111111,15.3694066415526,14.4334795321637,0.0670854858446815,0.098414748269609,"4851"
"R-HSA-1632852~Macroautophagy",0.0124223602484472,16.2145466921162,14.4334795321637,0.00832679067587717,0.0417364463738037,"79065, 8878"
"WP2572:Primary focal segmental glomerulosclerosis FSGS ",0.0111111111111111,15.3694066415526,14.4334795321637,0.0670854858446815,0.098414748269609,"4851"
"R-HSA-1980143~Signaling by NOTCH1",0.010989010989011,15.1555854294826,14.2357606344629,0.0679864859854306,0.0992328002514618,"4851"
"R-HSA-69202~Cyclin E associated events during G1/S transition ",0.010989010989011,15.1555854294826,14.2357606344629,0.0679864859854306,0.0992328002514618,"595"
"WP4216:Chromosomal and microsatellite instability in colorectal cancer ",0.010989010989011,15.1555854294826,14.2357606344629,0.0679864859854306,0.0992328002514618,"595"
"hsa05218_Melanoma",0.010989010989011,15.1555854294826,14.2357606344629,0.0679864859854306,0.0992328002514618,"595"
"WP2037:Prolactin signaling",0.0108695652173913,14.9476969886706,14.0433854907539,0.0688866617055542,0.100419900292082,"6654"
"hsa05226_Gastric_cancer",0.0120481927710843,15.6600459725795,13.94913458142,0.0088917354776705,0.0426778949947038,"595, 6654"
"R-HSA-69656~Cyclin A:Cdk2-associated events at S phase entry",0.010752688172043,14.745502716153,13.8561403508772,0.0697860137175308,0.101093523630909,"595"
"WP51:Regulation of actin cytoskeleton",0.0119760479041916,15.5536858213319,13.8561403508772,0.00900674758598173,0.0430239678074169,"10163, 6654"
"WP5356:Affected pathways in Duchenne muscular dystrophy",0.010752688172043,14.745502716153,13.8561403508772,0.0697860137175308,0.101093523630909,"1490"
"WP69:T cell receptor signaling",0.010752688172043,14.745502716153,13.8561403508772,0.0697860137175308,0.101093523630909,"6654"
"hsa01230_Biosynthesis_of_amino_acids",0.010752688172043,14.745502716153,13.8561403508772,0.0697860137175308,0.101093523630909,"4144"
"hsa04115_p53_signaling_pathway",0.010752688172043,14.745502716153,13.8561403508772,0.0697860137175308,0.101093523630909,"595"
"WP4666:Hepatitis B infection",0.0119047619047619,15.4487677926012,13.7643778319972,0.00912243113711281,0.0432193868627148,"3654, 6654"
"R-HSA-9009391~Extra-nuclear estrogen signaling",0.0106382978723404,14.5487735455613,13.6738227146814,0.0706845427332587,0.10201164968745,"595"
"R-HSA-9013694~Signaling by NOTCH4",0.0106382978723404,14.5487735455613,13.6738227146814,0.0706845427332587,0.10201164968745,"4851"
"WP4656:Joubert syndrome",0.0106382978723404,14.5487735455613,13.6738227146814,0.0706845427332587,0.10201164968745,"4646"
"R-HSA-1445148~Translocation of SLC2A4 (GLUT4) to the plasma membrane",0.0105263157894737,14.3572897241822,13.4962406015038,0.0715822494640569,0.103049913300685,"9371"
"hsa05212_Pancreatic_cancer",0.0105263157894737,14.3572897241822,13.4962406015038,0.0715822494640569,0.103049913300685,"595"
"R-HSA-9730414~MITF-M-regulated melanocyte development",0.0116279069767442,15.0429428541096,13.4091680814941,0.00959185465811985,0.0436082438037631,"595, 9275"
"hsa05100_Bacterial_invasion_of_epithelial_cells",0.0104166666666667,14.170840663343,13.3232118758435,0.0724791346206658,0.103823890485117,"10163"
"hsa05133_Pertussis",0.0104166666666667,14.170840663343,13.3232118758435,0.0724791346206658,0.103823890485117,"3654"
"hsa05140_Leishmaniasis",0.0104166666666667,14.170840663343,13.3232118758435,0.0724791346206658,0.103823890485117,"3654"
"hsa04218_Cellular_senescence",0.0114942528735632,14.847954604301,13.2383506537043,0.00983056247440078,0.0436082438037631,"595, 8878"
"hsa04390_Hippo_signaling_pathway",0.0114942528735632,14.847954604301,13.2383506537043,0.00983056247440078,0.0436082438037631,"1490, 595"
"GO:0007018~microtubule-based movement",0.0103092783505155,13.9892248129124,13.1545636242505,0.0733751989132473,0.104589062815923,"9371"
"R-HSA-6806834~Signaling by MET",0.0103092783505155,13.9892248129124,13.1545636242505,0.0733751989132473,0.104589062815923,"6654"
"R-HSA-3214858~RMTs methylate histone arginines",0.0103092783505155,13.9892248129124,13.1545636242505,0.0733751989132473,0.104589062815923,"595"
"GO:0006914~autophagy",0.0113636363636364,14.6579713204464,13.0718305196955,0.0100719210062553,0.0436082438037631,"79065, 8878"
"R-HSA-9612973~Autophagy",0.0113636363636364,14.6579713204464,13.0718305196955,0.0100719210062553,0.0436082438037631,"79065, 8878"
"hsa05160_Hepatitis_C",0.0113636363636364,14.6579713204464,13.0718305196955,0.0100719210062553,0.0436082438037631,"595, 6654"
"GO:0035591~signaling adaptor activity",0.0102040816326531,13.8122495303268,12.9901315789474,0.0742704430513871,0.105474978092633,"8878"
"R-HSA-74752~Signaling by Insulin receptor",0.0102040816326531,13.8122495303268,12.9901315789474,0.0742704430513871,0.105474978092633,"6654"
"hsa01521_EGFR_tyrosine_kinase_inhibitor_resistance",0.0102040816326531,13.8122495303268,12.9901315789474,0.0742704430513871,0.105474978092633,"6654"
"GO:0008104~protein localization",0.0112359550561798,14.4727965624339,12.9094475318732,0.0103159202938305,0.0436082438037631,"4646, 8878"
"WP4239:Epithelial to mesenchymal transition in colorectal cancer",0.0112359550561798,14.4727965624339,12.9094475318732,0.0103159202938305,0.0436082438037631,"4851, 6654"
"GO:0000082~G1/S transition of mitotic cell cycle",0.0101010101010101,13.639730927853,12.8297595841455,0.0751648677440909,0.105964130624596,"595"
"GO:0007265~Ras protein signal transduction",0.0101010101010101,13.639730927853,12.8297595841455,0.0751648677440909,0.105964130624596,"6654"
"GO:0008544~epidermis development",0.0101010101010101,13.639730927853,12.8297595841455,0.0751648677440909,0.105964130624596,"1490"
"GO:0048009~insulin-like growth factor receptor signaling pathway",0.0101010101010101,13.639730927853,12.8297595841455,0.0751648677440909,0.105964130624596,"6654"
"GO:0007254~JNK cascade",0.0101010101010101,13.639730927853,12.8297595841455,0.0751648677440909,0.105964130624596,"3654"
"R-HSA-416482~G alpha (12/13) signalling events",0.0101010101010101,13.639730927853,12.8297595841455,0.0751648677440909,0.105964130624596,"6654"
"hsa05161_Hepatitis_B",0.0111111111111111,14.2922431056522,12.7510494026477,0.0105625504022956,0.0436082438037631,"3654, 6654"
"R-HSA-5628897~TP53 Regulates Metabolic Genes",0.01,13.4604260609349,12.6732991014121,0.0760584736997894,0.10696301167513,"2744"
"WP2004:miR targeted genes in lymphocytes",0.0117924528301887,17.0296380434631,12.6732991014121,3.44501930391332e-05,0.00757108560694584,"4144, 4851, 57532, 595, 79065"
"WP2261:Glioblastoma signaling",0.01,13.4604260609349,12.6732991014121,0.0760584736997894,0.10696301167513,"595"
"WP2005:miR targeted genes in muscle cell",0.0115606936416185,15.8132613078246,12.5584353633328,0.000246329696897956,0.0189838086409358,"4851, 57532, 595, 79065"
"GO:0001889~liver development",0.0099009900990099,13.2965711563852,12.5206087507926,0.0769512616263374,0.107955896165104,"4851"
"KW-0503~Monooxygenase",0.0099009900990099,13.2965711563852,12.5206087507926,0.0769512616263374,0.107955896165104,"9645"
"hsa04140_Autophagy",0.0108108108108108,13.8599286050058,12.3715538847118,0.011190570542704,0.0444209166045696,"79065, 8878"
"hsa04630_JAK-STAT_signaling_pathway",0.0108108108108108,13.8599286050058,12.3715538847118,0.011190570542704,0.0444209166045696,"595, 6654"
"hsa05225_Hepatocellular_carcinoma",0.010752688172043,13.7765701579357,12.2983494238555,0.0113181266789693,0.0444209166045696,"595, 6654"
"GO:0001503~ossification",0.00970873786407767,12.9805486894175,12.2260061919505,0.0787343862205133,0.109791255091572,"1490"
"GO:0003779~actin binding",0.0112676056338028,15.3835955246431,12.2260061919505,0.00027286074475154,0.0197141888082988,"10163, 4646, 9275, 9645"
"GO:0031490~chromatin DNA binding",0.00970873786407767,12.9805486894175,12.2260061919505,0.0787343862205133,0.109791255091572,"4851"
"R-HSA-190236~Signaling by FGFR",0.00970873786407767,12.9805486894175,12.2260061919505,0.0787343862205133,0.109791255091572,"6654"
"KW-0072~Autophagy",0.0106951871657754,13.6827647533158,12.2260061919505,0.0114463306475366,0.0444209166045696,"79065, 8878"
"WP4018:Clear cell renal cell carcinoma pathways",0.00970873786407767,12.9805486894175,12.2260061919505,0.0787343862205133,0.109791255091572,"8878"
"WP2571:Polycystic kidney disease pathway",0.00970873786407767,12.9805486894175,12.2260061919505,0.0787343862205133,0.109791255091572,"595"
"GO:0010508~positive regulation of autophagy",0.00961538461538462,12.8280876249802,12.0838433292534,0.0796247243009727,0.110499617397268,"8878"
"R-HSA-2029480~Fcgamma receptor (FCGR) dependent phagocytosis",0.00961538461538462,12.8280876249802,12.0838433292534,0.0796247243009727,0.110499617397268,"10163"
"WP4336:ncRNAs in Wnt signaling in hepatocellular carcinoma",0.00961538461538462,12.8280876249802,12.0838433292534,0.0796247243009727,0.110499617397268,"595"
"hsa04012_ErbB_signaling_pathway",0.00961538461538462,12.8280876249802,12.0838433292534,0.0796247243009727,0.110499617397268,"6654"
"WP138:Androgen receptor signaling",0.00952380952380952,12.6791432562516,11.9449485783424,0.0805142471779385,0.111200083318634,"595"
"WP2446:Retinoblastoma gene in cancer",0.00952380952380952,12.6791432562516,11.9449485783424,0.0805142471779385,0.111200083318634,"595"
"hsa04662_B_cell_receptor_signaling_pathway",0.00952380952380952,12.6791432562516,11.9449485783424,0.0805142471779385,0.111200083318634,"6654"
"R-HSA-5389840~Mitochondrial translation elongation",0.00943396226415094,12.5335867436804,11.8092105263158,0.0814029555563911,0.112025972170462,"124995"
"R-HSA-5419276~Mitochondrial translation termination",0.00943396226415094,12.5335867436804,11.8092105263158,0.0814029555563911,0.112025972170462,"124995"
"R-HSA-5368286~Mitochondrial translation initiation",0.00943396226415094,12.5335867436804,11.8092105263158,0.0814029555563911,0.112025972170462,"124995"
"GO:0001525~angiogenesis",0.0106382978723404,13.8622777364506,11.7204194697269,0.00199668693820012,0.0358506144328846,"10163, 1490, 4851"
"GO:0045444~fat cell differentiation",0.00934579439252336,12.3907735934974,11.6765227675931,0.0822908501407338,0.112577778417383,"595"
"WP231:TNF alpha signaling",0.00934579439252336,12.3907735934974,11.6765227675931,0.0822908501407338,0.112577778417383,"6654"
"WP4263:Pancreatic adenocarcinoma pathway",0.00934579439252336,12.3907735934974,11.6765227675931,0.0822908501407338,0.112577778417383,"595"
"hsa04727_GABAergic_synapse",0.00934579439252336,12.3907735934974,11.6765227675931,0.0822908501407338,0.112577778417383,"2744"
"R-HSA-9700206~Signaling by ALK in cancer",0.00925925925925926,12.2510127464935,11.546783625731,0.0831779316347984,0.113255228468583,"8878"
"R-HSA-9013404~RAC2 GTPase cycle",0.00925925925925926,12.2510127464935,11.546783625731,0.0831779316347984,0.113255228468583,"10163"
"R-HSA-9725370~Signaling by ALK fusions and activated point mutants",0.00925925925925926,12.2510127464935,11.546783625731,0.0831779316347984,0.113255228468583,"8878"
"WP1772:Apoptosis modulation and signaling",0.00925925925925926,12.2510127464935,11.546783625731,0.0831779316347984,0.113255228468583,"3654"
"WP3925:Amino acid metabolism",0.00909090909090909,11.9807063242315,11.295766590389,0.0849496581645491,0.115125210830268,"2744"
"WP23:B cell receptor signaling",0.00909090909090909,11.9807063242315,11.295766590389,0.0849496581645491,0.115125210830268,"6654"
"WP4963:p53 transcriptional gene network",0.00909090909090909,11.9807063242315,11.295766590389,0.0849496581645491,0.115125210830268,"4851"
"hsa04540_Gap_junction",0.00909090909090909,11.9807063242315,11.295766590389,0.0849496581645491,0.115125210830268,"6654"
"R-HSA-9013149~RAC1 GTPase cycle",0.00985221674876847,12.4882630474108,11.1743067345784,0.0135847027544118,0.0473704468954306,"10163, 6654"
"hsa04520_Adherens_junction",0.00900900900900901,11.8499599657745,11.1743067345784,0.0858343046050359,0.115781162337715,"10163"
"hsa04658_Th1_and_Th2_cell_differentiation",0.00900900900900901,11.8499599657745,11.1743067345784,0.0858343046050359,0.115781162337715,"4851"
"hsa04912_GnRH_signaling_pathway",0.00900900900900901,11.8499599657745,11.1743067345784,0.0858343046050359,0.115781162337715,"6654"
"hsa05222_Small_cell_lung_cancer",0.00900900900900901,11.8499599657745,11.1743067345784,0.0858343046050359,0.115781162337715,"595"
"GO:0032543~mitochondrial translation",0.00892857142857143,11.7220248375071,11.055431131019,0.0867181407648416,0.116429931154654,"124995"
"R-HSA-5368287~Mitochondrial translation",0.00892857142857143,11.7220248375071,11.055431131019,0.0867181407648416,0.116429931154654,"124995"
"KW-0358~Heparin-binding",0.00892857142857143,11.7220248375071,11.055431131019,0.0867181407648416,0.116429931154654,"1490"
"WP4258:lncRNA in canonical Wnt signaling and colorectal cancer",0.00892857142857143,11.7220248375071,11.055431131019,0.0867181407648416,0.116429931154654,"595"
"GO:0007411~axon guidance",0.00970873786407767,12.2861507601948,10.9969367864105,0.0140036713867903,0.0473704468954306,"4851, 6654"
"R-HSA-9013423~RAC3 GTPase cycle",0.00884955752212389,11.5968109937221,10.9390581717452,0.0876011673449379,0.117207117419848,"10163"
"KW-0009~Actin-binding",0.00996677740863787,12.9231351863448,10.9390581717452,0.00242947809137934,0.0358506144328846,"10163, 4646, 9645"
"WP4658:Small cell lung cancer",0.00884955752212389,11.5968109937221,10.9390581717452,0.0876011673449379,0.117207117419848,"595"
"WP75:Toll like receptor signaling",0.00884955752212389,11.5968109937221,10.9390581717452,0.0876011673449379,0.117207117419848,"3654"
"R-HSA-975871~MyD88 cascade initiated on plasma membrane",0.00869565217391304,11.3542061820079,10.7135105805752,0.0893647945670292,0.119015786312772,"3654"
"R-HSA-4420097~VEGFA-VEGFR2 Pathway",0.00869565217391304,11.3542061820079,10.7135105805752,0.0893647945670292,0.119015786312772,"10163"
"R-HSA-168142~Toll Like Receptor 10 (TLR10) Cascade",0.00869565217391304,11.3542061820079,10.7135105805752,0.0893647945670292,0.119015786312772,"3654"
"R-HSA-168176~Toll Like Receptor 5 (TLR5) Cascade",0.00869565217391304,11.3542061820079,10.7135105805752,0.0893647945670292,0.119015786312772,"3654"
"GO:0006897~endocytosis",0.00943396226415094,11.9007680666437,10.6585695006748,0.0148584131445381,0.0481744002068905,"10163, 4646"
"GO:0046330~positive regulation of JNK cascade",0.00862068965517241,11.2366535606642,10.6041890440387,0.0902453966081137,0.120050262921725,"1490"
"R-HSA-9711123~Cellular response to chemical stress",0.00934579439252336,11.7775746701163,10.5503606732567,0.0151482711763634,0.0481744002068905,"4851, 8878"
"hsa04814_Motor_proteins",0.00934579439252336,11.7775746701163,10.5503606732567,0.0151482711763634,0.0481744002068905,"4646, 9371"
"GO:0070374~positive regulation of ERK1 and ERK2 cascade",0.00930232558139535,11.7169202342473,10.4970760233918,0.0152941218649903,0.0481744002068905,"1490, 4851"
"hsa04666_Fc_gamma_R-mediated_phagocytosis",0.00854700854700855,11.1229460300657,10.4970760233918,0.0911251918676673,0.121081289424165,"10163"
"WP306:Focal adhesion",0.00925925925925926,11.6570758518412,10.4443268976461,0.0154405854224031,0.0485035781203748,"595, 6654"
"GO:0016055~Wnt signaling pathway",0.00921658986175115,11.5978702489395,10.3921052631579,0.0155876606657115,0.0487009073771959,"595, 9275"
"GO:0007409~axonogenesis",0.00847457627118644,11.0101315155475,10.3921052631579,0.0920041810438108,0.121689740602569,"4851"
"GO:0043130~ubiquitin binding",0.00847457627118644,11.0101315155475,10.3921052631579,0.0920041810438108,0.121689740602569,"8878"
"R-HSA-983705~Signaling by the B Cell Receptor (BCR)",0.00847457627118644,11.0101315155475,10.3921052631579,0.0920041810438108,0.121689740602569,"6654"
"R-HSA-9845323~Regulation of endogenous retroelements by Piwi-interacting RNAs (piRNAs)",0.00847457627118644,11.0101315155475,10.3921052631579,0.0920041810438108,0.121689740602569,"9275"
"hsa05207_Chemical_carcinogenesis",0.00921658986175115,11.5978702489395,10.3921052631579,0.0155876606657115,0.0487009073771959,"595, 6654"
"hsa05205_Proteoglycans_in_cancer",0.00917431192660551,11.5392602866744,10.3404032469233,0.0157353464135259,0.0487615066210666,"595, 6654"
"GO:1990830~cellular response to leukemia inhibitory factor",0.00840336134453781,10.8995646081299,10.2892131318395,0.0928823648340965,0.122013651986609,"4144"
"R-HSA-9679191~Potential therapeutics for SARS",0.00840336134453781,10.8995646081299,10.2892131318395,0.0928823648340965,0.122013651986609,"6654"
"WP185:Integrin mediated cell adhesion",0.00840336134453781,10.8995646081299,10.2892131318395,0.0928823648340965,0.122013651986609,"6654"
"WP2064:Neural crest differentiation",0.00840336134453781,10.8995646081299,10.2892131318395,0.0928823648340965,0.122013651986609,"4851"
"hsa04933_AGE-RAGE_signaling_pathway_in_diabetic_complications",0.00840336134453781,10.8995646081299,10.2892131318395,0.0928823648340965,0.122013651986609,"595"
"hsa04510_Focal_adhesion",0.00909090909090909,11.4237892214005,10.2385273528649,0.0160325447046058,0.0487615066210666,"595, 6654"
"WP399:Wnt signaling and pluripotency",0.00833333333333333,10.7911781487927,10.1883384932921,0.0937597439355093,0.123026406344437,"595"
"hsa05169_Epstein-Barr_virus_infection",0.00904977375565611,11.3671013599189,10.1883384932921,0.0161820548925795,0.0487615066210666,"3654, 595"
"GO:0007173~epidermal growth factor receptor signaling pathway",0.00826446280991736,10.6849077045431,10.0894225855902,0.0946363190444656,0.123615350073901,"6654"
"R-HSA-975138~TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation",0.00826446280991736,10.6849077045431,10.0894225855902,0.0946363190444656,0.123615350073901,"3654"
"WP3998:Prader Willi and Angelman syndrome",0.00826446280991736,10.6849077045431,10.0894225855902,0.0946363190444656,0.123615350073901,"595"
"hsa05142_Chagas_disease",0.00826446280991736,10.6849077045431,10.0894225855902,0.0946363190444656,0.123615350073901,"3654"
"R-HSA-975155~MyD88 dependent cascade initiated on endosome",0.00819672131147541,10.5804169268922,9.99240890688259,0.0955120908568141,0.124477989887798,"3654"
"WP4536:Genes related to primary cilium development based on CRISPR ",0.00819672131147541,10.5804169268922,9.99240890688259,0.0955120908568141,0.124477989887798,"9371"
"GO:0007507~heart development",0.00881057268722467,11.0322170304688,9.89724310776942,0.017091796657971,0.0502392381251346,"4851, 9645"
"GO:0007160~cell-matrix adhesion",0.00813008130081301,10.4796485549119,9.89724310776942,0.0963870600678385,0.125335704655142,"1490"
"hsa04064_NF-kappa_B_signaling_pathway",0.00813008130081301,10.4796485549119,9.89724310776942,0.0963870600678385,0.125335704655142,"3654"
"R-HSA-168164~Toll Like Receptor 3 (TLR3) Cascade",0.00806451612903226,10.3739150611857,9.8038728897716,0.0972612273722533,0.126047061482427,"3654"
"R-HSA-6811434~COPI-dependent Golgi-to-ER retrograde traffic",0.00806451612903226,10.3739150611857,9.8038728897716,0.0972612273722533,0.126047061482427,"9371"
"WP5366:NF1 copy number variation syndrome ",0.00806451612903226,10.3739150611857,9.8038728897716,0.0972612273722533,0.126047061482427,"6654"
"GO:0006869~lipid transport",0.008,10.2764255303176,9.71224790949336,0.0981345934642096,0.126894396023072,"79065"
"R-HSA-8878166~Transcriptional regulation by RUNX2",0.008,10.2764255303176,9.71224790949336,0.0981345934642096,0.126894396023072,"595"
"WP3888:VEGFA VEGFR2 signaling",0.00896860986547085,12.0468017526268,9.64464525583099,0.000668939394935647,0.0317823680497783,"1490, 4646, 595, 9645"
"R-HSA-194138~Signaling by VEGF",0.00793650793650794,10.180520666558,9.62231968810916,0.0990071590372911,0.127594510420411,"10163"
"R-HSA-168181~Toll Like Receptor 7/8 (TLR7/8) Cascade",0.00793650793650794,10.180520666558,9.62231968810916,0.0990071590372911,0.127594510420411,"3654"
"WP4321:Thermogenesis",0.00793650793650794,10.180520666558,9.62231968810916,0.0990071590372911,0.127594510420411,"6654"
"GO:0007229~integrin-mediated signaling pathway",0.0078740157480315,10.086218374773,9.53404152583293,0.0998789247845182,0.128146545006552,"1490"
"R-HSA-6785807~Interleukin-4 and Interleukin-13 signaling",0.0078740157480315,10.086218374773,9.53404152583293,0.0998789247845182,0.128146545006552,"595"
"WP5380:5q35 copy number variation",0.0078740157480315,10.086218374773,9.53404152583293,0.0998789247845182,0.128146545006552,"6654"
"hsa04620_Toll-like_receptor_signaling_pathway",0.0078740157480315,10.086218374773,9.53404152583293,0.0998789247845182,0.128146545006552,"3654"
"hsa05165_Human_papillomavirus_infection",0.00862068965517241,11.0490030843276,9.39045656309448,0.00373799457357623,0.0361256119250341,"4851, 595, 6654"
"R-HSA-166166~MyD88-independent TLR4 cascade ",0.00775193798449612,9.90241770362493,9.36225699383594,0.101620059570661,0.129947775291686,"3654"
"R-HSA-168138~Toll Like Receptor 9 (TLR9) Cascade",0.00775193798449612,9.90241770362493,9.36225699383594,0.101620059570661,0.129947775291686,"3654"
"R-HSA-937061~TRIF (TICAM1)-mediated TLR4 signaling ",0.00775193798449612,9.90241770362493,9.36225699383594,0.101620059570661,0.129947775291686,"3654"
"GO:0035264~multicellular organism growth",0.00769230769230769,9.812891589346,9.27866541353383,0.102489429992794,0.130482137744129,"6654"
"R-HSA-156580~Phase II - Conjugation of compounds",0.00769230769230769,9.812891589346,9.27866541353383,0.102489429992794,0.130482137744129,"4144"
"WP5426:HDAC6 interactions in the central nervous system",0.00769230769230769,9.812891589346,9.27866541353383,0.102489429992794,0.130482137744129,"8878"
"hsa05145_Toxoplasmosis",0.00769230769230769,9.812891589346,9.27866541353383,0.102489429992794,0.130482137744129,"3654"
"GO:0038023~signaling receptor activity",0.00826446280991736,10.2840368489389,9.2374269005848,0.0194599102774581,0.0530557931149566,"4851, 8878"
"R-HSA-166058~MyD88:MAL(TIRAP) cascade initiated on plasma membrane",0.00763358778625954,9.72491832558058,9.19655333022822,0.103358003355506,0.131092990802291,"3654"
"R-HSA-6811558~PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling",0.00763358778625954,9.72491832558058,9.19655333022822,0.103358003355506,0.131092990802291,"3654"
"R-HSA-168188~Toll Like Receptor TLR6:TLR2 Cascade",0.00763358778625954,9.72491832558058,9.19655333022822,0.103358003355506,0.131092990802291,"3654"
"hsa05163_Human_cytomegalovirus_infection",0.00823045267489712,10.236882604029,9.19655333022822,0.0196224790429068,0.0533731429967066,"595, 6654"
"R-HSA-187037~Signaling by NTRK1 (TRKA)",0.00757575757575758,9.63803891904055,9.11588180978763,0.104225780348999,0.131821665299171,"6654"
"WP428:Wnt signaling",0.00757575757575758,9.63803891904055,9.11588180978763,0.104225780348999,0.131821665299171,"595"
"R-HSA-9758941~Gastrulation",0.0075187969924812,9.5517321880474,9.03661327231121,0.105092761662909,0.132772931674669,"4851"
"R-HSA-157118~Signaling by NOTCH",0.00806451612903226,10.0145585095936,8.99749373433584,0.0204440047112645,0.0547066422366245,"4851, 595"
"R-HSA-168179~Toll Like Receptor TLR1:TLR2 Cascade",0.00746268656716418,9.47271953328602,8.95871143375681,0.105958947986312,0.133429786353134,"3654"
"R-HSA-181438~Toll Like Receptor 2 (TLR2) Cascade",0.00746268656716418,9.47271953328602,8.95871143375681,0.105958947986312,0.133429786353134,"3654"
"hsa04724_Glutamatergic_synapse",0.00746268656716418,9.47271953328602,8.95871143375681,0.105958947986312,0.133429786353134,"2744"
"hsa04810_Regulation_of_actin_cytoskeleton",0.00803212851405622,9.97018488607909,8.95871143375681,0.0206100382432785,0.0547167043767625,"10163, 6654"
"R-HSA-449147~Signaling by Interleukins",0.00833333333333333,11.1392950906404,8.9394453876627,0.000888572692293218,0.0317823680497783,"3654, 595, 6654, 8878"
"GO:0007219~Notch signaling pathway",0.00740740740740741,9.38984541044136,8.8821412505623,0.106824340007722,0.134227105487964,"4851"
"hsa03082_ATP-dependent_chromatin_remodeling",0.00740740740740741,9.38984541044136,8.8821412505623,0.106824340007722,0.134227105487964,"9275"
"GO:0060271~cilium assembly",0.00790513833992095,9.79687639116192,8.80686886708296,0.0212798958804891,0.0553051807674503,"4851, 9371"
"GO:0008286~insulin receptor signaling pathway",0.00735294117647059,9.30858419816858,8.80686886708296,0.107688938415092,0.135019970507426,"6654"
"WP3931:Embryonic stem cell pluripotency pathways",0.00735294117647059,9.30858419816858,8.80686886708296,0.107688938415092,0.135019970507426,"6654"
"GO:0051092~positive regulation of NF-kappaB transcription factor activity",0.0072992700729927,9.22885153967733,8.7328615656789,0.108552743895812,0.135808411194328,"3654"
"WP4787:Osteoblast differentiation and related diseases",0.0072992700729927,9.22885153967733,8.7328615656789,0.108552743895812,0.135808411194328,"4851"
"R-HSA-199418~Negative regulation of the PI3K/AKT network",0.0072463768115942,9.1505740489147,8.66008771929824,0.109415757136717,0.136298076778065,"3654"
"R-HSA-2454202~Fc epsilon receptor (FCERI) signaling",0.0072463768115942,9.1505740489147,8.66008771929824,0.109415757136717,0.136298076778065,"6654"
"WP179:Cell cycle",0.0072463768115942,9.1505740489147,8.66008771929824,0.109415757136717,0.136298076778065,"595"
"WP2431:Spinal cord injury",0.0072463768115942,9.1505740489147,8.66008771929824,0.109415757136717,0.136298076778065,"595"
"GO:0006366~transcription by RNA polymerase II",0.00775193798449612,9.58897825189605,8.62415374535925,0.0221300111378154,0.0557348428656093,"4851, 8878"
"GO:0007264~small GTPase-mediated signal transduction",0.00719424460431655,9.07368753123873,8.58851674641148,0.110277978824075,0.137076713463044,"6654"
"R-HSA-69206~G1/S Transition",0.00719424460431655,9.07368753123873,8.58851674641148,0.110277978824075,0.137076713463044,"595"
"WP4549:Fragile X syndrome",0.00714285714285714,8.99813549061422,8.51811906816221,0.111139409643599,0.137555843199144,"6654"
"hsa04152_AMPK_signaling_pathway",0.00714285714285714,8.99813549061422,8.51811906816221,0.111139409643599,0.137555843199144,"595"
"hsa04660_T_cell_receptor_signaling_pathway",0.00714285714285714,8.99813549061422,8.51811906816221,0.111139409643599,0.137555843199144,"6654"
"hsa04935_Growth_hormone_synthesis,_secretion_and_action",0.00714285714285714,8.99813549061422,8.51811906816221,0.111139409643599,0.137555843199144,"6654"
"GO:0019901~protein kinase binding",0.00790513833992095,10.529700753251,8.46607353414085,0.00108789937439756,0.033989504778475,"3654, 595, 6654, 8878"
"GO:0001934~positive regulation of protein phosphorylation",0.00704225352112676,8.85084004070277,8.38073005093379,0.112859901419198,0.139535878118281,"595"
"hsa05131_Shigellosis",0.00754716981132075,9.31164139989803,8.38073005093379,0.0233438016049955,0.0571878044143478,"10163, 8878"
"GO:0019899~enzyme binding",0.0077120822622108,9.80446570800597,8.35826160575702,0.00517564997948803,0.0391711933141871,"4851, 595, 8878"
"R-HSA-9705671~SARS-CoV-2 activates/modulates innate and adaptive immune responses",0.00699300699300699,8.77901184674605,8.31368421052632,0.113718963743903,0.140447780008496,"3654"
"hsa05132_Salmonella_infection",0.00746268656716418,9.19861132641576,8.28056196267561,0.0238723527720986,0.0572540244907594,"3654, 4646"
"GO:0010629~negative regulation of gene expression",0.00743494423791822,9.16147412283461,8.24770258980785,0.0240496423846823,0.0575598066184115,"1490, 4851"
"GO:0009410~response to xenobiotic stimulus",0.00740740740740741,9.12460824522939,8.21510297482838,0.024227483098707,0.0576504516479662,"4646, 595"
"GO:0042826~histone deacetylase binding",0.00689655172413793,8.63862968185906,8.18276004973062,0.115434724684514,0.142414665672677,"595"
"KW-0254~Endocytosis",0.00675675675675676,8.43646122331878,7.99392712550607,0.118002467058891,0.145272472758337,"4646"
"hsa04926_Relaxin_signaling_pathway",0.00675675675675676,8.43646122331878,7.99392712550607,0.118002467058891,0.145272472758337,"6654"
"R-HSA-2132295~MHC class II antigen presentation",0.00671140939597315,8.37136479463853,7.93290478103656,0.118856810832834,0.14616858864123,"9371"
"WP3915:Angiopoietin like protein 8 regulatory pathway",0.00666666666666667,8.30642166504476,7.87280701754386,0.119710370565381,0.147061836741318,"6654"
"R-HSA-166520~Signaling by NTRKs",0.00662251655629139,8.24169200234784,7.81361297981797,0.120563146936118,0.147952227025639,"6654"
"hsa04650_Natural_killer_cell_mediated_cytotoxicity",0.00657894736842105,8.18138982499481,7.75530243519246,0.121415140624075,0.148682100171007,"6654"
"hsa03010_Ribosome",0.0065359477124183,8.11994733579964,7.69785575048733,0.122266352307728,0.149407931572658,"124995"
"GO:0016477~cell migration",0.00694444444444444,8.50659997950041,7.66945037871431,0.0275216025054903,0.0607834784103088,"1490, 23080"
"GO:0046777~protein autophosphorylation",0.00649350649350649,8.05941770456701,7.64125386996904,0.123116782665003,0.150129747637915,"3654"
"R-HSA-202733~Cell surface interactions at the vascular wall",0.00649350649350649,8.05941770456701,7.64125386996904,0.123116782665003,0.150129747637915,"6654"
"WP2380:Brain derived neurotrophic factor BDNF signaling",0.00645161290322581,7.99978188307055,7.58547829427584,0.123966432373268,0.150753179950632,"8878"
"WP5461:Primary ovarian insufficiency",0.00645161290322581,7.99978188307055,7.58547829427584,0.123966432373268,0.150753179950632,"79065"
"R-HSA-453279~Mitotic G1 phase and G1/S transition",0.00641025641025641,7.9410213897831,7.53051106025934,0.124815302109341,0.151243699411318,"595"
"hsa04380_Osteoclast_differentiation",0.00641025641025641,7.9410213897831,7.53051106025934,0.124815302109341,0.151243699411318,"8878"
"hsa04910_Insulin_signaling_pathway",0.00641025641025641,7.9410213897831,7.53051106025934,0.124815302109341,0.151243699411318,"6654"
"R-HSA-112315~Transmission across Chemical Synapses",0.00677966101694915,8.28799109950942,7.47633472169633,0.0288494042809998,0.06264494291799,"2744, 4646"
"hsa04915_Estrogen_signaling_pathway",0.00636942675159236,7.88311824693336,7.47633472169633,0.125663392549485,0.152111918101785,"6654"
"R-HSA-8856688~Golgi-to-ER retrograde transport",0.00632911392405063,7.82605493034304,7.42293233082707,0.126510704369416,0.152658010700464,"9371"
"WP5083:Neuroinflammation and glutamatergic signaling",0.00632911392405063,7.82605493034304,7.42293233082707,0.126510704369416,0.152658010700464,"2744"
"hsa05418_Fluid_shear_stress_and_atherosclerosis",0.00632911392405063,7.82605493034304,7.42293233082707,0.126510704369416,0.152658010700464,"8878"
"GO:0090090~negative regulation of canonical Wnt signaling pathway",0.00628930817610063,7.76981432971973,7.37028742067936,0.127357238244294,0.152722995239008,"4851"
"KW-0037~Angiogenesis",0.00628930817610063,7.76981432971973,7.37028742067936,0.127357238244294,0.152722995239008,"4851"
"WP2884:NRF2 pathway",0.00628930817610063,7.76981432971973,7.37028742067936,0.127357238244294,0.152722995239008,"8878"
"WP2853:Endoderm differentiation",0.00628930817610063,7.76981432971973,7.37028742067936,0.127357238244294,0.152722995239008,"4851"
"GO:0019221~cytokine-mediated signaling pathway",0.00625,7.714379717459,7.31838398813936,0.128202994848729,0.15357788812967,"6654"
"GO:0007015~actin filament organization",0.00617283950617284,7.60586332069361,7.21673976608187,0.129892178941965,0.155440330079618,"4646"
"R-HSA-9842860~Regulation of endogenous retroelements",0.00609756097560976,7.50037877847694,7.11788031723143,0.131578262035,0.157132717884773,"9275"
"WP2857:Mesodermal commitment pathway",0.00609756097560976,7.50037877847694,7.11788031723143,0.131578262035,0.157132717884773,"595"
"WP5087:Pleural mesothelioma",0.00659340659340659,8.29323793074151,7.1016664668505,0.00811608322195193,0.0417364463738037,"1490, 595, 6654"
"R-HSA-166016~Toll Like Receptor 4 (TLR4) Cascade",0.00606060606060606,7.44873516574549,7.06945936269245,0.132420142387127,0.157812045978886,"3654"
"R-HSA-3781865~Diseases of glycosylation",0.00606060606060606,7.44873516574549,7.06945936269245,0.132420142387127,0.157812045978886,"4851"
"hsa04072_Phospholipase_D_signaling_pathway",0.00598802395209581,7.34757133220502,6.97456729071,0.134101584059165,0.15965131943604,"6654"
"GO:0004672~protein kinase activity",0.00632911392405063,7.69442907613746,6.95124097870093,0.0329850740124922,0.0670714339467148,"3654, 595"
"GO:0043524~negative regulation of neuron apoptotic process",0.00595238095238095,7.29802242606264,6.9280701754386,0.134941146720059,0.160320622413554,"595"
"R-HSA-69242~S Phase",0.00595238095238095,7.29802242606264,6.9280701754386,0.134941146720059,0.160320622413554,"595"
"hsa04010_MAPK_signaling_pathway",0.00630914826498423,7.6682713066558,6.9280701754386,0.0331875953438762,0.0670714339467148,"3654, 6654"
"R-HSA-9018519~Estrogen-dependent gene expression",0.00591715976331361,7.24914355409498,6.88218891599861,0.135779938157279,0.161151548778043,"595"
"R-HSA-9012999~RHO GTPase cycle",0.00638297872340425,8.01161485027768,6.8670299095757,0.0088973812229443,0.0426778949947038,"10163, 4646, 6654"
"R-HSA-5663202~Diseases of signal transduction by growth factor receptors and second messengers",0.00632911392405063,7.93967477715415,6.80705584923006,0.00911299549740323,0.0432193868627148,"4851, 6654, 8878"
"WP1984:Integrated breast cancer pathway",0.00584795321637427,7.15334171762941,6.7922256621947,0.137455210036642,0.162972536207547,"595"
"hsa01240_Biosynthesis_of_cofactors",0.00581395348837209,7.1063923675444,6.74812030075188,0.138291691815394,0.163461345335987,"4144"
"hsa04921_Oxytocin_signaling_pathway",0.00581395348837209,7.1063923675444,6.74812030075188,0.138291691815394,0.163461345335987,"595"
"GO:0007010~cytoskeleton organization",0.00578034682080925,7.06006027718194,6.70458404074703,0.139127405043688,0.16377930777037,"9645"
"GO:0042127~regulation of cell population proliferation",0.00578034682080925,7.06006027718194,6.70458404074703,0.139127405043688,0.16377930777037,"6654"
"hsa04934_Cushing_syndrome",0.00578034682080925,7.06006027718194,6.70458404074703,0.139127405043688,0.16377930777037,"595"
"WP2882:Nuclear receptors meta pathway",0.00604229607250755,7.31983734772743,6.61917532685216,0.0360748901138584,0.0688161270158751,"595, 8878"
"hsa04150_mTOR_signaling_pathway",0.00571428571428571,6.96623500078408,6.61917532685216,0.140796528516119,0.165407303825847,"6654"
"hsa04110_Cell_cycle",0.00568181818181818,6.92171863048918,6.57728181212525,0.141629940092502,0.166048895280864,"595"
"GO:0007605~sensory perception of sound",0.00564971751412429,6.87777051007898,6.53591525984773,0.142462585782921,0.166350251681876,"4646"
"KW-0112~Calmodulin-binding",0.00564971751412429,6.87777051007898,6.53591525984773,0.142462585782921,0.166350251681876,"4646"
"WP437:EGF EGFR signaling",0.00564971751412429,6.87777051007898,6.53591525984773,0.142462585782921,0.166350251681876,"6654"
"hsa04217_Necroptosis",0.00564971751412429,6.87777051007898,6.53591525984773,0.142462585782921,0.166350251681876,"8878"
"GO:0005178~integrin binding",0.00561797752808989,6.83437927081375,6.49506578947368,0.14329446625214,0.166984277205115,"1490"
"WP481:Insulin signaling",0.00561797752808989,6.83437927081375,6.49506578947368,0.14329446625214,0.166984277205115,"6654"
"GO:0003735~structural constituent of ribosome",0.00558659217877095,6.79153381217134,6.45472376593658,0.14412558216438,0.167783658592169,"124995"
"R-HSA-9658195~Leishmania infection",0.00546448087431694,6.62483095262629,6.29824561403509,0.147442413508968,0.171127941783501,"10163"
"R-HSA-9824443~Parasitic Infection Pathways",0.00546448087431694,6.62483095262629,6.29824561403509,0.147442413508968,0.171127941783501,"10163"
"WP3929:Chemokine signaling",0.00546448087431694,6.62483095262629,6.29824561403509,0.147442413508968,0.171127941783501,"6654"
"KW-0344~Guanine-nucleotide releasing factor",0.0053475935828877,6.46579874447668,6.14917471192775,0.150747064938613,0.174787970981982,"6654"
"WP4172:PI3K Akt signaling",0.00561797752808989,6.76686597663742,6.13103555348548,0.041465548137279,0.0751126036058332,"595, 6654"
"WP5434:Cancer pathways",0.00571428571428571,7.11946788039563,6.12501292524041,0.012135392247683,0.0466952107769898,"4851, 595, 6654"
"hsa04530_Tight_junction",0.00531914893617021,6.42721634271713,6.11300309597523,0.15157132963856,0.175567592246669,"595"
"WP5316:Primary ovarian insufficiency",0.00529100529100529,6.38908766581316,6.07725453985842,0.152394836393956,0.17634477564706,"79065"
"R-HSA-168898~Toll-like Receptor Cascades",0.00526315789473684,6.35140478546277,6.04192166462668,0.153217585863074,0.177119529257713,"3654"
"GO:0030182~neuron differentiation",0.00520833333333333,6.27734561816201,5.9724742891712,0.154860815572883,0.178305879285113,"595"
"R-HSA-983231~Factors involved in megakaryocyte development and platelet production",0.00520833333333333,6.27734561816201,5.9724742891712,0.154860815572883,0.178305879285113,"9371"
"KW-0445~Lipid transport",0.00520833333333333,6.27734561816201,5.9724742891712,0.154860815572883,0.178305879285113,"79065"
"hsa04310_Wnt_signaling_pathway",0.00520833333333333,6.27734561816201,5.9724742891712,0.154860815572883,0.178305879285113,"595"
"hsa05200_Pathways_in_cancer",0.00547445255474453,6.80246379951605,5.86020973486347,0.0136672713832358,0.0473704468954306,"4851, 595, 6654"
"GO:0008201~heparin binding",0.00510204081632653,6.13428052474767,5.83826138379657,0.158138216461552,0.181898286795577,"1490"
"hsa04151_PI3K-Akt_signaling_pathway",0.00527704485488127,6.32714421789551,5.74149462052922,0.0466793803821313,0.0805833983427133,"595, 6654"
"hsa05152_Tuberculosis",0.0050251256281407,6.03115111151484,5.74149462052922,0.160588361551836,0.184532948264336,"3654"
"hsa05168_Herpes_simplex_virus_1_infection",0.005,5.99753457350329,5.70994794679005,0.161403574245074,0.185285533095636,"3654"
"WP4223:Ras signaling",0.00495049504950495,5.93140392197607,5.64788329519451,0.163031750041334,0.186968951436291,"6654"
"GO:0030674~protein-macromolecule adaptor activity",0.00492610837438424,5.89887779121127,5.61735419630156,0.16384471444751,0.187715054411617,"8878"
"KW-0689~Ribosomal protein",0.00490196078431373,5.86670332887259,5.58715336728919,0.164656930726933,0.188272415351468,"124995"
"WP2877:Vitamin D receptor pathway",0.00490196078431373,5.86670332887259,5.58715336728919,0.164656930726933,0.188272415351468,"595"
"GO:0046982~protein heterodimerization activity",0.0051150895140665,6.11931490942482,5.55727554179567,0.0494923335032594,0.0822558263724018,"3654, 6654"
"GO:0004888~transmembrane signaling receptor activity",0.00485436893203883,5.80338677645448,5.52771556550952,0.166279121505965,0.189751889892296,"4851"
"hsa05034_Alcoholism",0.00485436893203883,5.80338677645448,5.52771556550952,0.166279121505965,0.189751889892296,"6654"
"hsa04062_Chemokine_signaling_pathway",0.004739336492891,5.65086594077391,5.38451049904554,0.170321551687432,0.194173287722555,"6654"
"KW-0053~Apoptosis",0.00503355704697987,6.22114831513333,5.37522686025408,0.0172099812262572,0.0502392381251346,"10904, 8878, 9275"
"hsa05167_Kaposi_sarcoma-associated_herpesvirus_infection",0.00469483568075117,5.59205846251355,5.32928475033738,0.171933318652972,0.195624917679957,"595"
"KW-0879~Wnt signaling pathway",0.00467289719626168,5.56383560472169,5.30209452201933,0.172738089340727,0.196347326723579,"9275"
"R-HSA-1280215~Cytokine Signaling in Immune system",0.00495049504950495,6.39940890460262,5.24191942656136,0.00617829974146559,0.0410466350639898,"3654, 595, 6654, 8878"
"R-HSA-9705683~SARS-CoV-2-host interactions",0.00452488687782805,5.36921528110076,5.11926367643246,0.178350772114654,0.202527988766739,"3654"
"GO:0006412~translation",0.00448430493273543,5.31605310842226,5.06931964056483,0.17994775760394,0.203940791951131,"124995"
"hsa05203_Viral_carcinogenesis",0.00448430493273543,5.31605310842226,5.06931964056483,0.17994775760394,0.203940791951131,"595"
"GO:0003714~transcription corepressor activity",0.00444444444444444,5.26379431931899,5.02034070683956,0.181541802202907,0.204943675143125,"595"
"R-HSA-5617833~Cilium Assembly",0.00444444444444444,5.26379431931899,5.02034070683956,0.181541802202907,0.204943675143125,"9371"
"R-HSA-376176~Signaling by ROBO receptors",0.00444444444444444,5.26379431931899,5.02034070683956,0.181541802202907,0.204943675143125,"6654"
"R-HSA-9679506~SARS-CoV Infections",0.00458715596330275,5.44718532404213,4.96043210651928,0.0605747454872785,0.0923387932277473,"3654, 6654"
"R-HSA-112316~Neuronal System",0.0045766590389016,5.43396123803336,4.94862155388471,0.06083018682095,0.0923387932277473,"2744, 4646"
"GO:0005516~calmodulin binding",0.00436681222707424,5.16204304880278,4.92516837116488,0.184721089183019,0.208126295414785,"4646"
"R-HSA-6811442~Intra-Golgi and retrograde Golgi-to-ER traffic",0.00436681222707424,5.16204304880278,4.92516837116488,0.184721089183019,0.208126295414785,"9371"
"R-HSA-112314~Neurotransmitter receptors and postsynaptic signal transmission",0.00434782608695652,5.13755399390436,4.9019364448858,0.185514080854234,0.208816239014113,"4646"
"hsa05170_Human_immunodeficiency_virus_1_infection",0.00432900432900433,5.11326010388564,4.87892265875958,0.186306341769801,0.209504018566041,"3654"
"GO:0051015~actin filament binding",0.00429184549356223,5.0637006530289,4.83353733170135,0.187888673877569,0.211078043734179,"4646"
"hsa05417_Lipid_and_atherosclerosis",0.00427350427350427,5.04001771070058,4.81115984405458,0.188678746340259,0.211579064038763,"3654"
"R-HSA-416476~G alpha (q) signalling events",0.00425531914893617,5.01653495747715,4.78898860053359,0.189468090588277,0.212233636356636,"6654"
"GO:0030036~actin cytoskeleton organization",0.00420168067226891,4.94728604901745,4.72368421052632,0.191831760381136,0.214465681818755,"10163"
"GO:0016491~oxidoreductase activity",0.00420168067226891,4.94728604901745,4.72368421052632,0.191831760381136,0.214465681818755,"9645"
"GO:0001701~in utero embryonic development",0.004149377593361,4.87981927578882,4.66013688930847,0.194188899032771,0.216472871052925,"4851"
"GO:0016301~kinase activity",0.004149377593361,4.87981927578882,4.66013688930847,0.194188899032771,0.216472871052925,"3654"
"R-HSA-8939211~ESR-mediated signaling",0.004149377593361,4.87981927578882,4.66013688930847,0.194188899032771,0.216472871052925,"595"
"hsa05166_Human_T-cell_leukemia_virus_1_infection",0.00413223140495868,4.85772046681673,4.63933270676692,0.194973163499443,0.217137742779727,"595"
"R-HSA-211859~Biological oxidations",0.00409836065573771,4.81409823822302,4.59827666511411,0.19653952358965,0.218461239682342,"4144"
"hsa05208_Chemical_carcinogenesis",0.00409836065573771,4.81409823822302,4.59827666511411,0.19653952358965,0.218461239682342,"6654"
"R-HSA-8878171~Transcriptional regulation by RUNX1",0.00408163265306122,4.79257118061802,4.57801993971713,0.197321620472267,0.219119878257387,"595"
"GO:0007268~chemical synaptic transmission",0.0040650406504065,4.77123094391025,4.55794090489381,0.198102996085087,0.219776452470596,"2744"
"GO:0043123~positive regulation of canonical NF-kappaB signal transduction",0.00403225806451613,4.72910296614901,4.51830663615561,0.19966358601383,0.221295403098742,"3654"
"R-HSA-8951664~Neddylation",0.004,4.68751151679988,4.4793557168784,0.201221298395712,0.222808257610578,"8878"
"GO:0035556~intracellular signal transduction",0.0041407867494824,4.88366506379856,4.46013101423086,0.072981873239519,0.104414660228817,"3654, 8878"
"hsa04714_Thermogenesis",0.00398406374501992,4.66689539106253,4.46013101423086,0.201999077073029,0.223455438369781,"6654"
"GO:0006511~ubiquitin-dependent protein catabolic process",0.00396825396825397,4.6464812765722,4.44107062528115,0.202776138242341,0.223886548049805,"8878"
"GO:0005085~guanyl-nucleotide exchange factor activity",0.00396825396825397,4.6464812765722,4.44107062528115,0.202776138242341,0.223886548049805,"6654"
"GO:0030154~cell differentiation",0.004149377593361,5.06559765075071,4.40966277078836,0.0288867939855386,0.06264494291799,"4851, 8878, 9275"
"hsa05171_Coronavirus_disease",0.00393700787401575,4.60753277261828,4.40343443354148,0.204328110557106,0.225384824240472,"3654"
"hsa04014_Ras_signaling_pathway",0.00390625,4.56801338402036,4.36643078283945,0.205877220335194,0.2268770893303,"6654"
"R-HSA-194315~Signaling by Rho GTPases",0.00410396716826265,5.00631336734612,4.36032388663968,0.0297353641885558,0.0631876489006811,"10163, 4646, 6654"
"R-HSA-9716542~Signaling by Rho GTPases, Miro GTPases and RHOBTB3",0.00401606425702811,4.8928964369161,4.26488588091295,0.0314727281557774,0.064852894381602,"10163, 4646, 6654"
"GO:0008284~positive regulation of cell population proliferation",0.00392156862745098,4.60752991779683,4.21586420412085,0.0804596016695938,0.111200083318634,"4851, 9275"
"GO:0004711~ribosomal protein S6 kinase activity",0.00377358490566038,4.39858614610397,4.20733006605583,0.212812923967352,0.230996939066909,"3654"
"GO:0044022~histone H3S28 kinase activity",0.00377358490566038,4.39858614610397,4.20733006605583,0.212812923967352,0.230996939066909,"3654"
"GO:0044023~histone H4S1 kinase activity",0.00377358490566038,4.39858614610397,4.20733006605583,0.212812923967352,0.230996939066909,"3654"
"GO:0004676~3-phosphoinositide-dependent protein kinase activity",0.00377358490566038,4.39858614610397,4.20733006605583,0.212812923967352,0.230996939066909,"3654"
"GO:0072371~histone H2AS121 kinase activity",0.00377358490566038,4.39858614610397,4.20733006605583,0.212812923967352,0.230996939066909,"3654"
"GO:0072354~histone H3T3 kinase activity",0.00377358490566038,4.39858614610397,4.20733006605583,0.212812923967352,0.230996939066909,"3654"
"GO:0044024~histone H2AS1 kinase activity",0.00377358490566038,4.39858614610397,4.20733006605583,0.212812923967352,0.230996939066909,"3654"
"GO:1990244~histone H2AT120 kinase activity",0.00377358490566038,4.39858614610397,4.20733006605583,0.212812923967352,0.230996939066909,"3654"
"GO:0140855~histone H3S57 kinase activity",0.00377358490566038,4.39858614610397,4.20733006605583,0.212812923967352,0.230996939066909,"3654"
"GO:0035175~histone H3S10 kinase activity",0.00377358490566038,4.39858614610397,4.20733006605583,0.212812923967352,0.230996939066909,"3654"
"GO:0072518~Rho-dependent protein serine/threonine kinase activity",0.00377358490566038,4.39858614610397,4.20733006605583,0.212812923967352,0.230996939066909,"3654"
"GO:0004694~eukaryotic translation initiation factor 2alpha kinase activity",0.00377358490566038,4.39858614610397,4.20733006605583,0.212812923967352,0.230996939066909,"3654"
"GO:0035979~histone H2AXS139 kinase activity",0.00377358490566038,4.39858614610397,4.20733006605583,0.212812923967352,0.230996939066909,"3654"
"GO:0140823~histone H2BS36 kinase activity",0.00377358490566038,4.39858614610397,4.20733006605583,0.212812923967352,0.230996939066909,"3654"
"GO:0044025~histone H2BS14 kinase activity",0.00377358490566038,4.39858614610397,4.20733006605583,0.212812923967352,0.230996939066909,"3654"
"WP382:MAPK signaling",0.00377358490566038,4.39858614610397,4.20733006605583,0.212812923967352,0.230996939066909,"6654"
"GO:0004677~DNA-dependent protein kinase activity",0.0037593984962406,4.38054747705939,4.19036502546689,0.213580005434405,0.231395019945804,"3654"
"GO:0140857~histone H3T45 kinase activity",0.0037593984962406,4.38054747705939,4.19036502546689,0.213580005434405,0.231395019945804,"3654"
"GO:0035403~histone H3T6 kinase activity",0.00374531835205993,4.36265655549464,4.17353625026422,0.214346378717308,0.231790845460438,"3654"
"GO:0035402~histone H3T11 kinase activity",0.00374531835205993,4.36265655549464,4.17353625026422,0.214346378717308,0.231790845460438,"3654"
"GO:0004679~AMP-activated protein kinase activity",0.00373134328358209,4.34491115472616,4.15684210526316,0.215112044433576,0.232401423705808,"3654"
"GO:0016192~vesicle-mediated transport",0.00371747211895911,4.32730914816466,4.14028098133781,0.215877003200223,0.233010098692304,"9371"
"R-HSA-212436~Generic Transcription Pathway",0.00393700787401575,5.27340502270098,4.1369845792826,0.00567035854873782,0.0391711933141871,"1490, 2744, 3654, 4851, 595"
"WP5115:Network map of SARS CoV 2 signaling",0.00367647058823529,4.27528441547028,4.09138002486531,0.218167643964942,0.23504361269662,"3654"
"R-HSA-76002~Platelet activation, signaling and aggregation",0.00354609929078014,4.11110988065074,3.93640350877193,0.225757414571057,0.242542352457381,"6654"
"R-HSA-1257604~PIP3 activates AKT signaling",0.00354609929078014,4.11110988065074,3.93640350877193,0.225757414571057,0.242542352457381,"3654"
"R-HSA-9006934~Signaling by Receptor Tyrosine Kinases",0.00362976406533575,4.24394304005576,3.89217425586438,0.0922595793513876,0.12188808426309,"10163, 6654"
"R-HSA-74160~Gene expression (Transcription)",0.00371517027863777,5.2423970040946,3.89217425586438,0.00304423166023954,0.0361256119250341,"1490, 2744, 3654, 4851, 595, 9275"
"R-HSA-5668914~Diseases of metabolism",0.00350877192982456,4.06372432402835,3.89217425586438,0.228020699840631,0.244746452196629,"4851"
"GO:0030335~positive regulation of cell migration",0.0034965034965035,4.04830003044166,3.87765121759623,0.228773734377187,0.245326935936946,"4851"
"R-HSA-5673001~RAF/MAP kinase cascade",0.00348432055749129,4.03299112501451,3.86323615730777,0.229526072984099,0.245905598118275,"6654"
"KW-0221~Differentiation",0.00364520048602673,4.4121134348913,3.86323615730777,0.0404546043346637,0.073901414736864,"4851, 8878, 9275"
"GO:0008017~microtubule binding",0.00342465753424658,3.95813538961767,3.79273914713792,0.2332773483175,0.249001490909538,"9371"
"R-HSA-5684996~MAPK1/MAPK3 signaling",0.00342465753424658,3.95813538961767,3.79273914713792,0.2332773483175,0.249001490909538,"6654"
"R-HSA-3247509~Chromatin modifying enzymes",0.00342465753424658,3.95813538961767,3.79273914713792,0.2332773483175,0.249001490909538,"595"
"R-HSA-4839726~Chromatin organization",0.00342465753424658,3.95813538961767,3.79273914713792,0.2332773483175,0.249001490909538,"595"
"GO:0006886~intracellular protein transport",0.00341296928327645,3.94349384983709,3.77894736842105,0.234025524085666,0.249569654836744,"4646"
"R-HSA-73857~RNA Polymerase II Transcription",0.00358937544867193,4.76951016065006,3.76798595473455,0.00839819375409121,0.0417364463738037,"1490, 2744, 3654, 4851, 595"
"hsa05020_Prion_disease",0.00338983050847458,3.91453135281174,3.7516625498765,0.235519801162206,0.250931695984802,"4851"
"GO:0005096~GTPase activator activity",0.00335570469798658,3.87187272814326,3.71146616541353,0.237756039679639,0.253081014612949,"6654"
"GO:0003713~transcription coactivator activity",0.00333333333333333,3.84394464763023,3.68514371033968,0.239243420988639,0.254429985890401,"4851"
"GO:0031267~small GTPase binding",0.00321543408360129,3.69726099384483,3.54679360517334,0.247374992605663,0.262594574336223,"9371"
"R-HSA-72766~Translation",0.00321543408360129,3.69726099384483,3.54679360517334,0.247374992605663,0.262594574336223,"124995"
"R-HSA-9006931~Signaling by Nuclear Receptors",0.00317460317460317,3.64666156796125,3.4990253411306,0.250311459189765,0.265467932865475,"595"
"R-HSA-9694516~SARS-CoV-2 Infection",0.00315457413249211,3.62107817320501,3.47562048935047,0.251775619017671,0.26677599961909,"3654"
"KW-0687~Ribonucleoprotein",0.00314465408805031,3.6088182601827,3.4640350877193,0.252506682641998,0.267305609097207,"124995"
"GO:0031625~ubiquitin protein ligase binding",0.00311526479750779,3.57253246833775,3.42973771061317,0.254695815460958,0.269130130413956,"8878"
"WP3932:Focal adhesion PI3K Akt mTOR signaling",0.00311526479750779,3.57253246833775,3.42973771061317,0.254695815460958,0.269130130413956,"6654"
"R-HSA-1852241~Organelle biogenesis and maintenance",0.0031055900621118,3.56059906013907,3.41845567867036,0.255424175686565,0.269653285017049,"9371"
"R-HSA-9006925~Intracellular signaling by second messengers",0.00308641975308642,3.53697009256403,3.39611283109735,0.256878873608728,0.2709415856676,"3654"
"R-HSA-1643685~Disease",0.00321888412017167,4.47263868138862,3.36859165742557,0.00625253370212275,0.0413024511980223,"10163, 3654, 4851, 595, 6654, 8878"
"GO:0006974~DNA damage response",0.00304878048780488,3.4905757433691,3.35229202037351,0.259780195832299,0.273751965708421,"595"
"GO:0043065~positive regulation of apoptotic process",0.00303951367781155,3.47913761156623,3.34151294635302,0.260503847814763,0.274264524657437,"8878"
"R-HSA-5683057~MAPK family signaling cascades",0.00301204819277108,3.44526141365114,3.30958766342608,0.262670784577026,0.276294292057363,"6654"
"KW-0391~Immunity",0.00309597523219814,3.5831878052472,3.30432599782445,0.12139497574462,0.148682100171007,"3654, 8878"
"R-HSA-109582~Hemostasis",0.00309119010819165,3.57730275377352,3.29908103592314,0.121713414409756,0.148889637098072,"6654, 9371"
"GO:0000122~negative regulation of transcription by RNA polymerase II",0.00309917355371901,3.70926511972696,3.27482308712959,0.0608669207954528,0.0923387932277473,"4851, 595, 8878"
"GO:0045296~cadherin binding",0.0029673590504451,3.39022042914571,3.25771324863884,0.26626898368618,0.279824495582931,"10163"
"R-HSA-212165~Epigenetic regulation of gene expression",0.00294117647058824,3.35801829515552,3.22736188296829,0.268419911547819,0.281828717301798,"9275"
"R-HSA-199991~Membrane Trafficking",0.00301659125188537,3.48551119631265,3.21737005051328,0.126838259208864,0.152722995239008,"4646, 9371"
"GO:0006915~apoptotic process",0.00301204819277108,3.47992535684884,3.21239729927601,0.127160392706636,0.152722995239008,"8878, 9275"
"R-HSA-195258~RHO GTPase Effectors",0.00286532951289398,3.2649226391646,3.1396088408332,0.274836910863503,0.288304418292387,"10163"
"GO:0006338~chromatin remodeling",0.00286944045911047,3.30483293269194,3.05650154798762,0.137905604678397,0.163339015377282,"3654, 9275"
"R-HSA-5663205~Infectious disease",0.00288739172281039,3.43820449845522,3.04753820033956,0.0723681208834398,0.103823890485117,"10163, 3654, 6654"
"KW-0131~Cell cycle",0.00285714285714286,3.28975665089237,3.04307621175927,0.138893072347691,0.16377930777037,"10904, 595"
"R-HSA-5653656~Vesicle-mediated transport",0.00284495021337127,3.27481259552053,3.02976829829676,0.139882238875829,0.164500374507079,"4646, 9371"
"GO:0044877~protein-containing complex binding",0.00275482093663912,3.12978546664602,3.01220442410374,0.284713025927015,0.298393706229945,"8878"
"KW-0945~Host-virus interaction",0.00282885431400283,3.25508989189585,3.01220442410374,0.141203741644445,0.16571728461013,"10163, 3654"
"R-HSA-168256~Immune System",0.00285442435775452,3.90843507920005,2.98480763901136,0.0112105032788491,0.0444209166045696,"10163, 3654, 595, 6654, 8878, 9371"
"GO:0042802~identical protein binding",0.00281214848143982,3.64756750551204,2.94560806778852,0.0227475781721256,0.0563305980107242,"3654, 4144, 4646, 4851, 8878"
"R-HSA-71291~Metabolism of amino acids and derivatives",0.00268817204301075,3.04858592710481,2.93562295569432,0.290994522174651,0.304700785900269,"2744"
"R-HSA-168249~Innate Immune System",0.00274725274725275,3.2591429142206,2.89742711798083,0.0815665755458642,0.112117671023804,"10163, 3654, 6654"
"R-HSA-3700989~Transcriptional Regulation by TP53",0.00264550264550265,2.99671588701907,2.88669590643275,0.295153114433853,0.308775565869262,"2744"
"GO:0106310~protein serine kinase activity",0.0026246719160105,2.97142596139594,2.86283891547049,0.297223734792954,0.310660612496071,"3654"
"R-HSA-1266738~Developmental Biology",0.00271923861318831,3.35575483389191,2.85497397339503,0.0467970048802305,0.0805833983427133,"4851, 595, 6654, 9275"
"hsa05014_Amyotrophic_lateral_sclerosis",0.00258397932816537,2.92208355842484,2.81628868920268,0.301347699928267,0.314686487007296,"8878"
"WP5420:ADHD and autism ASD pathways",0.0025706940874036,2.90599180831963,2.80110653993474,0.302717252728781,0.315831357540136,"2744"
"GO:0004674~protein serine/threonine kinase activity",0.00255102040816327,2.88217780312959,2.77863777089783,0.304766813949453,0.317682990915751,"3654"
"R-HSA-162582~Signal Transduction",0.00266058532877233,3.8220417781594,2.77757681718615,0.00841277638323475,0.0417364463738037,"10163, 3654, 4646, 4851, 595, 6654, 8878"
"GO:0005524~ATP binding",0.00264550264550265,3.25629317828336,2.77678163344232,0.0509902453851415,0.0832552594141576,"3654, 4144, 4646, 9371"
"GO:0051301~cell division",0.00246305418719212,2.7759277151072,2.67837764514379,0.314256200205359,0.32727943012378,"595"
"R-HSA-1280218~Adaptive Immune System",0.00250941028858218,2.86499597078038,2.66464237516869,0.171646515631934,0.195491006966026,"6654, 9371"
"KW-0723~Serine/threonine-protein kinase",0.00244498777506112,2.75405332287413,2.65782743303271,0.316273612931119,0.329083975291065,"3654"
"GO:0045944~positive regulation of transcription by RNA polymerase II",0.00248344370860927,2.92293890202271,2.61546273401625,0.103422843954749,0.131092990802291,"4851, 8878, 9645"
"GO:0008285~negative regulation of cell population proliferation",0.00240384615384615,2.70454690179874,2.61108172441153,0.320959065354983,0.333658884487734,"4851"
"GO:0006955~immune response",0.00239234449760766,2.69072010396258,2.59802631578947,0.322292168749892,0.334743708063679,"4851"
"R-HSA-2262752~Cellular responses to stress",0.0024330900243309,2.7721539103927,2.58188950637463,0.180311532036312,0.20415291971986,"4851, 8878"
"GO:0016887~ATP hydrolysis activity",0.00232558139534884,2.61053986951496,2.52235564639755,0.330238868085404,0.342382180723522,"9371"
"KW-0399~Innate immunity",0.00232558139534884,2.61053986951496,2.52235564639755,0.330238868085404,0.342382180723522,"3654"
"R-HSA-9824446~Viral Infection Pathways",0.00236406619385343,2.68830955384914,2.50714240365691,0.188700705038032,0.211579064038763,"3654, 6654"
"KW-0132~Cell division",0.0023094688221709,2.59115846583741,2.50412175015853,0.332211704632095,0.344118934188801,"595"
"GO:0007165~signal transduction",0.00229357798165138,2.68157753434408,2.41302753788496,0.124019268281186,0.150753179950632,"1490, 3654, 6654"
"KW-0227~DNA damage",0.00222222222222222,2.48703144771825,2.40557992202729,0.343287532111694,0.355273399392228,"595"
"GO:0010628~positive regulation of gene expression",0.0021505376344086,2.40137028210576,2.32485576357,0.352915583986482,0.364910925839332,"4851"
"R-HSA-8953897~Cellular responses to stimuli",0.00214362272240086,2.42124599872531,2.26901861641002,0.2195847559197,0.236350072479677,"4851, 8878"
"hsa05022_Pathways_of_neurodegeneration",0.00200400801603206,2.22750185949946,2.16052084473137,0.374246442967694,0.386620990232936,"8878"
"KW-0130~Cell adhesion",0.0019723865877712,2.19002141670262,2.12517490044129,0.379167747749183,0.391355282498264,"1490"
"GO:0001228~DNA-binding transcription activator activity, RNA polymerase II-specific",0.00196078431372549,2.17629117294054,2.11221651690201,0.381003765985269,0.39289951247009,"4851"
"GO:0007283~spermatogenesis",0.00188679245283019,2.08892280408749,2.02970805921053,0.393113065456402,0.405025582591445,"4851"
"R-HSA-422475~Axon guidance",0.00177935943060498,1.96256752733754,1.91031346749226,0.412022303056525,0.423752475385537,"6654"
"GO:0045087~innate immune response",0.00177619893428064,1.95885884349535,1.90680830516659,0.412604125682531,0.423973661590227,"3654"
"GO:0007155~cell adhesion",0.00175438596491228,1.93327736562309,1.88262776506484,0.416661638239545,0.427762747606495,"1490"
"R-HSA-69278~Cell Cycle, Mitotic",0.00175131348511384,1.92967622035417,1.87922337489293,0.41723911069687,0.427975520821279,"595"
"GO:0006357~regulation of transcription by RNA polymerase II",0.00176574455562095,2.01398489420968,1.85242518059856,0.216919507694086,0.233916931804444,"4851, 6654, 9275"
"R-HSA-9675108~Nervous system development",0.00170357751277683,1.87379889014946,1.82638053834058,0.426405336879579,0.436989866518433,"6654"
"GO:0045892~negative regulation of DNA-templated transcription",0.00169779286926995,1.86703727880437,1.81998340860909,0.427541463638168,0.437766104486911,"4851"
"KW-0560~Oxidoreductase",0.0016260162601626,1.78311298768374,1.74072114960769,0.442118457525778,0.452291094601592,"9645"
"KW-0678~Repressor",0.00154083204930663,1.68388482217359,1.64692634915339,0.460650619823676,0.47041706406022,"595"
"R-HSA-388396~GPCR downstream signalling",0.00152439024390244,1.66476958724971,1.62885662431942,0.464392960466453,0.473820178551827,"6654"
"KW-0653~Protein transport",0.0015220700152207,1.66207305920867,1.62630755291986,0.464925568084139,0.473945288099881,"4646"
"R-HSA-1640170~Cell Cycle",0.00142045454545455,1.5442130433903,1.51488414914838,0.489399772733739,0.498454746502381,"595"
"GO:0045893~positive regulation of DNA-templated transcription",0.00136798905608755,1.48355196391919,1.45751826972762,0.502975802454632,0.511380851044463,"4851"
"R-HSA-372790~Signaling by GPCR",0.00136798905608755,1.48355196391919,1.45751826972762,0.502975802454632,0.511380851044463,"6654"
"KW-0010~Activator",0.00136054421768707,1.47495462833301,1.44938706599134,0.504957742332097,0.512944771648422,"4851"
"GO:0003723~RNA binding",0.00136332651670075,1.48500006278576,1.43339382940109,0.411768247924406,0.423752475385537,"124995, 57532"
"GO:0005509~calcium ion binding",0.00134408602150538,1.45595766033791,1.43141945773525,0.509389766764253,0.516992599104018,"4851"
"KW-0694~RNA-binding",0.00133868808567604,1.44972976452682,1.42552884268284,0.51085873586376,0.518028683033778,"57532"
"KW-0418~Kinase",0.00132450331125828,1.4333703500764,1.41005498821681,0.514755642649788,0.521522807101801,"3654"
"GO:0042803~protein homodimerization activity",0.00130718954248366,1.41341464172619,1.39117875008807,0.519585422768618,0.525955121471561,"3654"
"GO:0005515~protein binding",0.00132538104705103,8.18076528519002,1.37745136035966,0.00782786074126999,0.0417364463738037,"10163, 10904, 124995, 1490, 157638, 2744, 3654, 4144, 4646, 4851, 57532, 595, 6654, 79065, 8878, 9275, 9371, 9645"
"hsa01100_Metabolic_pathways",0.00126422250316056,1.36709676097907,1.32806457037162,0.451194152410005,0.461167497953993,"2744, 4144"
"GO:0006355~regulation of DNA-templated transcription",0.00106044538706257,1.13046311916053,1.12347083926031,0.598299696442761,0.604575567384468,"4851"
"KW-0808~Transferase",0.000983284169124877,1.03407341020588,1.03045168697649,0.592012742604147,0.598746045888358,"3654, 4144"
"KW-0813~Transport",0.000965250965250965,1.01275079873944,1.01139710590344,0.602686304271098,0.608476303700776,"4646, 79065"
"KW-9996~Developmental protein",0.000956022944550669,1.01152298450615,1.01090518124104,0.638093624030913,0.641981052549814,"4851"
"KW-0217~Developmental protein",0.000956022944550669,1.01152298450615,1.01090518124104,0.638093624030913,0.641981052549814,"4851"
"R-HSA-392499~Metabolism of proteins",0.000927643784786642,0.968317655172093,0.971678846485077,0.625602235947444,0.631061243241925,"124995, 8878"
"R-HSA-1430728~Metabolism",0.000907852927825692,0.944946067814317,0.950787306784803,0.638014645589807,0.641981052549814,"2744, 4144"
"KW-0805~Transcription regulation",0.000833680700291788,0.857417749789847,0.872552918820982,0.686606904435599,0.690189201328307,"4851, 595"
"KW-0804~Transcription",0.000810701256586948,0.830381110026086,0.848335123523093,0.702279956391573,0.705330694690407,"4851, 595"
"GO:0046872~metal ion binding",0.000703977472720873,0.704726744784032,0.735984792008349,0.777991630717428,0.780692990546308,"4144, 9645"
"R-HSA-597592~Post-translational protein modification",0.000649350649350649,0.664936393098937,0.682792724254789,0.782340481512361,0.7843760595215,"8878"
"KW-0675~Receptor",0.000585137507314219,0.592931558479628,0.614553829873323,0.817670397140123,0.819087503547645,"4851"
"KW-0378~Hydrolase",0.000549752611324904,0.553292135703725,0.577018615389111,0.837668583223356,0.838393837407965,"2744"
"GO:0008270~zinc ion binding",0.000465332712889716,0.458959366757847,0.48766331596236,0.885932772973084,0.885932772973084,"8878"
